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Temporomandibular disorders (TMD) are defined as a group of disorders of 
the temporomandibular joint (TMJ) and its musculature (Durham and 
Wassel, 2011). The treatment of degenerative changes in TMJ disc and 
TMD is challenging with no permanent solution. The population of 
fibroblasts and chondrocytes in TMJ disc has provided a hope to treat this 
disorder using modern techniques (Mäenpää et al., 2010). 
Photobiomodulation and stem cell therapy have emerged as novel 
treatments for TMD and degenerative changes of the TMJ disc (Zhu Xu et 
al., 2018, Zhang et al., 2015). ADSCs have been proven to have the 
capacity to differentiate into many cell types and tissues (Mazini 2019). 
Research has shown that photobiomodulation increases stem cell 
proliferation (Mvula et al., 2010; Mvula and Abrahamse, 2014). Stem cell 
therapy has been used in an attempt to replace degenerative TMJ disc cells 
(Zhang et al., 2015).  However, despite significant improvements in the 
search for new treatments to improve TMDs, conclusive evidence of 
possible treatment regimes for degeneration of the TMJ disc remains to be 
discovered. 
The objective of this study was to explore the effect of laser irradiation with 
660 and 940 nm diode lasers in differentiating ADSCs into fibroblasts and 
chondrocytes. The laser irradiation with/without basic fibroblast growth 
factor (bFGF) was used to seek permanent treatment of degenerative TMJ 
disc. The study used immortal ADSCs purchased from ATCC for all 
experiments. The ADSCs were cultured in Dulbecco’s Modified Eagle 
Medium (DMEM) with 10% foetal bovine serum, antibiotic and antimycotic 
supplements (Zuk et al., 2001). The cultures were then incubated at 37°C 
in a humidified atmosphere of 5% carbon dioxide (CO2).  
The ADSCs were harvested at a confluence not more than 90% and the 
viable cell numbers were quantified using an Invitrogen Countess™ II FL 
automated cell counter for seeding calculations. The morphology and cell 
growth were observed in a 3,4 cm diameter plate with 2 ml of complete 
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media at time intervals of 24, 48, 72 h; and 1-week and 2, 3-weeks. The 
optimized ADSCs in each group were irradiated with 660 nm and 940 nm 
diode lasers with/without basic fibroblast growth factor (bFGF) at 5 J/cm2 
fluence, to induce differentiation into fibroblasts and chondrocytes.   The 
bFGF is a known strong mitogen for many cell types (Nukavarapu et al., 
2015; Desai et al., 2014). However, the use of bFGF was omitted in the 
differentiation of chondrocytes to avoid the interference of fibroblasts in 
culture. Hence, the significance of the laser alone in differentiation was 
determined. 
The experimental groups were divided into four: Group 1 (C) was a control 
group of ADSCs with no laser irradiation and basic fibroblast growth factor 
(bFGF) added. Group 2 (LB) with bFGF added at 10 ng/ml, before irradiation. 
Group 3 (B) with (10 ng/ml) bFGF alone and ADSCs exposed to laser 
irradiation alone, group 4 (L). Semiconfluent monolayer ADSCs were 
exposed to laser irradiation at 5 J/cm2 fluence with 660 nm and 940 nm diode 
lasers in separate experiments. The irradiated and non-irradiated ADSCs 
were re-incubated at 37°C in an 85% humidified atmosphere of 5% CO2. 
The morphology, viability (trypan blue exclusion test) and proliferation (ATP 
luminescence assay) of ADSCs were recorded at 24, 48 and 72 h; 1-week 
and 2, 3-weeks post irradiation. The markers CD26 and CD49C were used 
to confirm the differentiation of ADSCs to fibroblasts and chondrocytes 
respectively. Flow cytometry and immunofluorescence techniques were 
employed to identify the expression of these markers. The expression of 
CD26 marker was observed in all experimental groups and CD49C marker 
in L group.  
The results of this study confirmed the photobiomodulatory effects of 660
nm and 940 nm lasers, with increased cell proliferation and viability 
with/without bFGF in all experimental groups. No significant change in 
morphology and viability was observed beyond 72 h. However, the 
morphology, viability and ATP proliferation had marked differences beyond 
1-week indicating the possible change in stemness leading to differentiation. 
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The fluorescence tagged CD26 and CD49C antibody images proposed the 
differentiation through immunofluorescence. The flow cytometry analysis 
results were statistically significant at 1-week post-irradiation for both the 
wavelengths; and at 2-weeks with 660 nm, with the expression of CD26 in 
all experimental groups. Additionally, a significant expression of CD49C 
marker was recorded with both wavelengths.  
This study confirmed the photobiomodulatory effects of laser in inducing 
differentiation of ADSCs at 5 J/cm2 into functional fibroblasts and 
chondrocytes. The results are promising and can be taken further to 
investigate the effectiveness in in vivo and preclinical studies. The 
fibroblasts and chondrocytes obtained from laser differentiated ADSCs 
could be used for the replacement and tissue regeneration of damaged TMJ 
disc cells in a clinical setting. The outcomes of the current study will motivate 
the use of 660 nm and 940 nm diode lasers in modulating ADSCs for 
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Temporomandibular disorder is one of the most common chronic non-dental 
pain conditions in the population. Approximately thirty three percent of the 
general population will show more than one sign or symptom, only five percent 
seeks treatment (Wright and North, 2009). Temporomandibular disorder 
patients experience grinding of the teeth during sleep damaging silently the 
dentition, TMJ structures and muscles (Demjaha et al., 2019). Furthermore, 
the etiology of TMD is complicated and could be caused by systemic diseases 
(Ohrbach and Dworkin, 2016). The origin of the TMD includes injury to jaw, 
TMJ, TMJ disc and whiplash (Lee et al., 2017).  
The common treatment modalities for TMD patients in South Africa, African 
continent and worldwide are occlusal splint and relaxation therapy. A study 
confirmed the reduction of myogenous TMD symptoms in South African 
population following the application of relaxation therapy and occlusal 
splints (Miller et al., 2003). In another population a study measured reduced 
pain scores in twenty-eight out of thirty-three patients subjected to occlusal 
splint therapy (Okeson et al., 1982). Additionally, a modification of 
Jacobson’s technique has been used to treat TMD as a relaxation therapy 
(Okeson 2012). Furthermore, physical therapy and counselling have been 
used as a treatment for TMD patients to reduce pain and to improve function 
in patients globally (De Laat et al., 2003).  
However, the TMD patients often seek late treatment in the development of 
this disorder and usually with most of the treatment options already 
attempted for some wrongly diagnosed disease. This presents significant 
challenges in the treatment of TMD and degenerative TMJ disc changes 
(Murphy et al., 2013; Yokoyama et al., 2018). Nevertheless, there is no 
definitive modality of treatment for TMD, presenting great challenges for
TMD patients. Hence, new and emerging strategies like photobiomodulation 
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and stem cell therapy have been proposed in the therapy of TMD and 
deteriorating TMJ disc changes. 
1.2 Problem statement 
Temporomandibular disorders (TMD) are defined as a group of disorders of 
the temporomandibular joint (TMJ) and its musculature (Durham and 
Wassel, 2011). The difficult part of TMD treatment is the degenerative 
changes of the TMJ disc.  The TMJ disc is made from two-thirds of 
fibroblasts and one-third of chondrocytes (Mäenpää et al. 2010). Hence, an 
attempt was made to regenerate the TMJ disc with stem cells by Zhang et 
al. (2015). Among the stem cell type, Adipose Derived Stem Cells (ADSCs) 
have been proven to differentiate into many cell types (Mazini 2019). In a 
study, intra-articular injection of ADSCs inhibited joint degeneration in the 
knee of the rat with induced osteoarthritis (Stancker et al., 2018). 
Few studies have reported that stem cell proliferation was increased by 
photobiomodulation (Mvula et al., 2010; Mvula and Abrahamse, 2014; 
Mokoena et al., 2019). Photobiomodulation has been used to decrease 
inflammation and provoke regeneration of tissues affected by TMD (Carroll 
et al., 2014, Khan and Arany, 2015). Therefore, the combined application of 
stem cell therapy and photobiomodulation could provoke regeneration of 
tissues affected by TMD (Carroll et al., 2014). 
1.3 Aim of Study 
According to the literature survey, there are no research reports available on 
examining laser (660 nm and 940 nm) differentiation of human ADSCs to 
fibroblasts and chondrocytes (TMJ disc cells) beyond 72 h. Hence, the main 
objective of this research study was to monitor the effect of laser-induced 
differentiation of ADSCs into functional fibroblasts and chondrocyte (TMJ disc 
cells) at different time intervals (Mäenpää et al., 2010). To observe the
proliferation and viability of ADSCs post-irradiation with 660 nm and 940 nm 
diode laser. Additionally, the role of bFGF was also accessed in the 
differentiation process. The current study was designed to identify a future 
alternative method of treatment for patients with TMJ disc degenerative 
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changes using stem cells and photobiomodulation. To accomplish this, the 
following objectives were identified:  
 To optimize in vitro culture of adipose derived stem cells (ADSCs) for
use in photobiomodulation experiment the seeding densities for the 
group of cells cultured at different time intervals. 
 To irradiate the cells with 660 and 940 nm diode laser with and without 
bFGF. 
 To morphologically and biochemically assay ADSCs following laser 
irradiation at different timed intervals. 
 To confirm ADSCs differentiation into fibroblasts and chondrocytes in 





















2.1 Anatomy of Temporomandibular Joint  
The Temporomandibular joint (TMJ) is described as the most complex joint 
in the human body (Chang et al., 2018; Kranjcic et al., 2016). Mandible 
(lower jawbone) is a part of TMJ that develops during the sixth week of 
embryological development. During the development of the mandible the 
angle of the mandible (gonial angle) located at the ramus of the mandible; 
undergoes dimensional changes. Throughout one’s lifetime the angle 
decreases from 160 (childhood) to 120 degrees (adulthood) (Lipski et al., 
2013). An injury to any part of the mandible during the development can 
cause damage to the function of TMJ (Giannakopoulos et al., 2009).  
Masticatory muscles are the only structure that supports the lower jawbone. 
This complicated joint is made of mandibular condyle that is fitting into part 
of the temporal bone named mandibular or glenoid fossa (Okeson 1993). 
Temporomandibular joint disc prevents direct articulation of these two 
bones. The TMJ superior and inferior joint space and the TMJ disc are 
placed between the condyle and glenoid fossa, (Figure 2.1). 
 
Figure 2.1 The figure represents a panoramic radiograph of TMJ and full 
dentition in 20-year-old healthy female patient. The TMJ disc is situated 
between the condyle and glenoid fossa. TMJ - Temporomandibular joint.  
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2.2 Temporomandibular Disorder 
The TMD refers to a group of disorders affecting the TMJ and its related 
muscles (Durham and Wassell, 2011). The TMJ and its muscles could 
undergo acute or chronic changes with impairment of the TMJ disc, condyle 
and masticatory muscles. Many factors can play causative role in the 
formation of  acute TMD including injury to the jaw, the TMJ, the TMJ disc, 
or from whiplash (Lee et al., 2017). Temporomandibular disorder patients 
will experience sleep bruxism (grinding of the teeth) ; with damage to the 
dentition, TMJ structures and muscles (Demjaha et al., 2019). 
Additionally, TMD treatment has become difficult due to diverse populations
and cultures in the world. Hence, it has been recommended that the Axis‐II 
assessment tools need to be modified to have a better treatment target for 
TMD patients. Moreover, an improvement in worldwide education of 
undergraduate and post–graduate training in health care was also 
recommended (Sharma et al., 2019). Studies have shown that, 
approximately thirty-three percent of the general population show more than 
one sign or symptom related to the TMJ and only five percent will seek the 
treatment (Wright and North, 2009).  
The TMD patients are mainly female who often experience depression 
linked to it (Yap et al., 2003). Temporomandibular disorder can become 
chronic in a brief period, with a silent build-up of symptoms interlinked with 
systemic diseases. Thus patients report for the treatment only when 
persistent pain emerges and at a late stage, challenging dentists for 
treatment (Marqués-Mateo et al., 2016; Murphy et al., 2013; Yokoyama et 
al., 2018).  
Search for a more definitive solution for TMD has proposed several novel 
treatment strategies. These include photobiomodulation which describes the 
use of a visible light wavelength range of lasers (Anders et al., 2015; Hamblin 
2016). The studies have shown that photobiomodulation increases the 
mobility of TMJ, the quickening of tooth movement; including regeneration of 
the tissues (Cetiner et al., 2006; Tuner et al., 2019; Hosseinpour et al., 2019; 
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Gholami et al., 2019, Cronshaw et al., 2019; Farivar et al., 2014). Additionally, 
research studies have proposed the role of photobiomodulation and stem cell 
therapy in the replacement of damaged TMJ disc cells (Zhang et al., 2015).  
Furthermore , in general dentistry, Dental Pulp Stem Cells (DPSCs) have 
been considered as a major source of cells in bone tissue engineering. These 
cells can differentiate into bone-like tissues when seeded on scaffolds in 
animal models (Paduano et al., 2017). Additionally, the in vivo study reported 
that a combination of bioactive nanomaterials within the scaffold is a 
promising treatment for patients affected by osteoporosis (Kerativitayanan et 
al., 2017). The novel solution for tissue regeneration of craniofacial defects 
without growth factor has given new hope (Barry et al., 2016). 
Human periapical cyst, mesenchymal stem cells (MSCs) have been found 
very promising in tissue regeneration (Tatullo et al., 2017). However, the 
therapies with the MSCs and other stem cells, scaffolds and biomaterials 
could trigger inflammation and increase the oxidative stresses additionally 
to the disease. For example, the research study reported high levels of 
oxidative stress in female patients affected by Burning Mouth Syndrome 
(BMS) (Tatullo et al., 2012). While the conventional treatment of TMD has 
many challenges, it could be postulated that a combination of 
photobiomodulation and stem cell therapy may offer better treatment 
outcomes since photobiomodulation decreases inflammation. 
2.3 Etiology of Temporomandibular Disorder 
The etiology of TMD is complex and could originate in TMD and/or from
systemic diseases (Ohrbach and Dworkin, 2016). In addition, it has been 
found that many-gene polymorphisms could be associated with TMD (Melis 
and Di Giosia, 2016). Moreover, the neuromuscular source and/or 
psychological source could play a role in the formation of TMD.  In addition,  
TMD patient may suffer depression before or after developing TMD 
(Chisnoiu et al., 2015). Generalized chronic musculoskeletal pain disorder 
patients can experience the same symptoms as TMD patients as in the case
with arthritis (Suvinen and Reade, 1995; Dworkin and Massoth, 1994).  
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Bruxism (developing during the sleep), occlusal overloading and oestrogen 
hormones have been linked to TMD (Güler et al., 2003; Israel and Scrivani, 
2000; Le Resche et al., 1997; Berger et al., 2015). The coexistence of 
depression, stress and anxiety symptoms are recognized causes of TMD 
(Yap et al., 2002, Dıraçoǧlu et al., 2016). Anxiety is more associated with 
acute TMD. However, chronic TMD conditions are linked to depressive 
disorders (Al-Khotani et al., 2016; Gatchel et al 1996). Also, some 
antidepressants with selective serotonin reuptake inhibitors may cause 
bruxism (Rajan et al., 2017).  
Fracture of the mandible and whiplash injuries to the head and/or neck as a 
result of road traffic accidents are also linked to TMD (Probert 1994). The 
presence of TMD in patients before endotracheal intubation influences the 
appearance of TMD after intubations (Martin et al., 2007). Hypermobility and 
systemic hyperlaxity have also been connected to TMD. The genetic 
disorders Marfan and Ehler-Danlos syndromes in patients have 
experienced TMD caused by hyperextension of the TMJ. This could lead to 
the inability to open the mouth (open lock) and it is one of the major 
indications of TMJ luxation (De Coster et al., 2005).  
2.3.1. Biochemical changes related to TMD 
The biochemical changes related to complex aetiology of TMD and TMJ 
degenerative changes uncover unseen but very important additional causes 
of this disorder. A study confirmed the central role of reactive oxygen species 
(ROS) in the pathogenesis of TMD; the important implication in the treatment 
of  TMD disease (Wade-Vallance et al., 2017). Another study examined the 
role of aquaporins (AQPs) as a lineage of hydrophobic membrane channel 
proteins.  The AQP1 is found to be present in the TMJ disc as a part of normal 
structures, with specificity to fibrocartilage (Loreto et al., 2012).  
Marfan and Ehler-Danlos syndromes are genetic disorders with evidence of 
biochemical abnormalities linked to TMD (Holbrook and Byers, 1982). 
Biochemical analysis of synovial fluid (SF) of TMJ confirmed a positive 
association of visfatin concentrations with TMD pain and internal 
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derangement stage. The considerably higher concentration of visfatin was 
found in the condyle with osteoarthritis (Yapıcı et al., 2019). Additionally, the 
investigation of SF has proved the occurrence of inflammatory cytokines, 
and free radicals (Fu et al., 1995; Shinmei et al., 1992; Okada et al., 1986; 
Halliwell et al., 1985).  
Some studies have also explored inflammatory mediators like arachidonic 
acid metabolites, neuropeptides, proteinases, and glycosaminoglycan 
components as prime promoters of TMD. Cytokines and matrix 
metalloproteinases have been studied in this context (Milam and Schmitz, 
1995; Quinn and Bazan, 1990; Shibata et al., 1998; Alstergren et al., 1995; 
Ishimaru et al., 2000). The presence of these inflammatory arbitrators 
defines the deformation of cartilage and collagen that promotes movement 
activities of the mandible. Stress evoked by these mediators may generate 
free radicals in the TMJ (Milam et al., 1998).  
Free radicals are produced by the mechanical stress in the TMJ by hypoxia-
reperfusion, arachidonic acid metabolites, and pro-inflammatory cytokines. 
One study defined a hypothesis for disc displacement by observing the 
manifestation of unrestrained free radicals caused by joint overloading 
(Milam et al., 1998). The destruction of hyaluronic acid (HA), proteoglycan 
(PG) monomer, collagen, and cartilage in the TMJ could be one of the 
consequences of free radicals. In addition, an increase in inflammatory 
cytokines and proteinases in the TMJ could be the consequence of the 
distractive characteristic of free radicals (Nitzan et al., 2001). 
Constituents of the TMJ articular tissue under normal conditions are 
transferrin, ceruloplasmin, albumin, haptoglobin, ascorbic acid and, 
tocopheral (vitamin E). An impairment of fluid transport and production of 
free radical molecules are the result of the excessive mechanical loading of 
articular tissues of TMJ. Furthermore , the oxygen and the superoxide anion 
may be converted into free radical species by interactions with different 
molecules in degenerative joints (Kubota et al., 1998). The etiology of TMD 
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has gained a new way of exploration through the biochemical aspect 
offering a progressive path in support of diagnoses of TMD, (Figure 2.2).  
2.4 Cardinal Signs and Symptoms of TMD patients 
Pain in muscles and/or TMJ, joint sounds and limitation of movements are 
defined as cardinal signs and symptoms of TMD. This includes the TMJ disc 
degenerative disorder (Miller et al., 2014). Classification of TMD patients is 
done on the basis of the cardinal TMD signs and symptoms into two broad 
diagnostic categories. Myogenous TMD, with pain that predominantly 
originates from muscles and arthrogenous with pain originating from the 
TMJ bone structure (Tartaglia et al., 2008). The TMD could be linked with 
other symptoms like headache, earache, tinnitus, dizziness, numbness, 
allodynia, chronic fatigue, and sleep disorders (Lindroth et al., 2002).  
Irritable bowels syndrome and dysmenorrhea have also been recorded as 
functional disorders of joints related to TMD (Aaron et al., 2000).  
Headaches have been closely related to TMD in several studies (Lupoli and 
Lockey, 2007; Anderson et al., 2011). However, headaches could have an 
origin in other systemic disorders, diseases, and syndromes (Goncalves et 
al., 2011; Haley et al., 1993). Further on, the TMD could also be caused by 
different stages of various systemic diseases, such as Lyme disease and 
paroxysmal hemicranias (Heir and Fein, 1998).  
Also, it has been reported that there was a seven percent association of 
TMD with migraines. Whereas, the tension types of headaches were 
experienced in forty-six percent of cases associated with TMD (Marcus et 
al., 1994).  In some cases, the patients with facial pain and headaches may 
not present a causative connection with TMD which can complicate the 
diagnoses of TMD (Benoliel et al., 1998). However, the headaches with no 
origin linked to TMD are treated separately (Cooper and Kleinberg, 2009). 
The complex aetiology of TMD makes diagnoses of this disorder difficult.  
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Figure 2.2.  The figure lists several factors influencing the normal 
functioning of TMJ disc. The imbalance in these biochemical and genetic 
factors lead to TMD. Targeting these factors may be useful in the treatment 
of this disorder. TMD - temporomandibular disorder; TMJ - 
temporomandibular joint. 
2.5 Treatment and Management of Temporomandibular Disorder 
Multifactorial etiology and complexity of the clinical picture of TMD patient 
make the management of TMD very difficult. To improve the treatment 
results globally, The Research Diagnosis Criteria for TMD (RDC/TMD) were 
developed to establish the standard for evaluation of TMD named the dual 
axis system. This system was formed to improve the treatment of TMD 
patients worldwide (Suvinen et al., 2005). The hyaluronic (HA) joint injection, 
botulinum toxin (BTX) type A injection and arthrocentesis are the treatments 
in use (Abouelhuda et al., 2018). Nevertheless,  occlusal splint therapy and 




The occlusal splint was used as a treatment in a study reporting twenty-
eight out of the thirty-three patients showed reduced pain scores post-
treatment (Okeson et al., 1982). Modification of Jacobson’s technique has 
been used to treat TMD as a relaxation therapy (Okeson 2012). Additionally, 
the research study used physical therapy and counselling to treat pain 
parameters and to improve function in patients with pain in TMJ muscles 
(De Laat et al., 2003). However, there is no definitive modality of treatment 
for TMD. Thus, the exploration of a photobiomodulation as a de nova 
treatment is in progress. 
2.5.1 Photobiomodulation for Temporomandibular Disorder 
The Stimulated Emission of Radiation theory was described by Albert 
Einstein in 1917 taking the work of Niels Bohr onward. Einstein described 
the electrons of molecules being excited by a source of energy (heat), and 
directed in a specific way (Einstein,1917). The first working laser was 
developed by Theodore Maiman (Maiman,1960).  When electrons are 
excited the spontaneously emitted photons are released. The photons are 
focused by mirrors at each end of the laser tube and emitted into the delivery 
system of a laser.  Light Amplification by Stimulated Emission of Radiation 
represents acronym “LASER” (Convissor 2016). 
Lasers are classified according to wavelength as low (visible) and high 
output lasers. The term low-level laser therapy has been replaced with 
‘photobiomodulation’  (Anders et al., 2015; Hamblin 2016).  The lasers used 
for photobiomodulation are within the visible range of wavelength. 
Additionally, the lasers used in dentistry are mostly in mid -infrared range. 
This classification directs dentists to decide which lasers to use for different 






Table 2.1.  General classification of lasers to low (visible) and high output 
lasers with application in dentistry. 
Lasers Wavelength Application in 
dentistry 
Ultraviolet 180 nm to 400 nm Not used in dentistry 
Visible 400 nm to 700 nm The most commonly 
used in dentistry for 
diagnoses of caries 
(Argon and 
Diagnodent Lasers) 
Infrared 700 nm to 1 mm The widest range of 
dental lasers are 
within this range 
 
Furthermore, the classification of dental lasers has been done based on the 
lasing medium and material used, including gas laser and solid laser, (Kang 
et al., 2014) (Table 2.2). 
Table 2.2. The classification of dental lasers according to lasing media and 
material used. 
Types of dental 
lasers classified 
according to lasing 
media 





Argon  Gas 488 – 510   nm 
Diodes  Solid 830 – 1064 nm 
Nd: YAG * Solid 1064 nm 
Ho: YAG** Solid 632.8 nm 
Erbium   Solid 2790 – 2940 nm 
CO2    Gas 9.3 – 10.6     nm 
 
* Nd: YAG: neodymium-yttrium aluminium garnet. 
** Ho:YAG: holmium-yttrium aluminium garnet. 
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Lasers in dentistry are classified according to the affinity for the different 
tissue types. This classification is specifically related to hard and soft tissues 
according to the tissue affinity of the laser. For instance, the erbium-doped 
yttrium aluminium garnet laser (Er: YAG) at 2940 nm wavelength can be 
applied for hard and soft tissue preparation. In addition, as erbium, chromium-
doped yttrium, scandium, gallium and garnet (Er: YSGG) of 2780 nm 
wavelength can be utilized for cavity preparation and surgical procedures. 
Nevertheless, soft tissue lasers cannot be used for the treatment of hard 
tissues (Verma et al., 2012; Arany and Wilder-Smith, 2016).  
Laser therapy has emerged as a pain therapy for TMD patients (Zhu Xu et 
al., 2018). The improvement in immunomodulation, decrease in 
inflammation and promotion of wound healing; and tissue regeneration was 
confirmed with photobiomodulation (Khan and Arany, 2015). Also, a 
decrease in pain was reported in patients with TMD after the laser treatment 
(Carroll et al., 2014). The improvement in general TMD symptoms was 
reported with 660 nm and 740 nm lasers (De Oliveira et al., 2017). Even 
though photobiomodulation offers a novel modality of TMD treatment, laser 
research has restricted outcome measures (a wide variety of treatment
parameters) that are confining the present treatment (Rahman et al., 2018).  
Furthermore, it has been shown that laser light expands the usual biological 
mechanisms in the human body. The laser light mainly affects damaged 
cells with decreased oxidation–reduction (redox) reactions. An increase of 
adenosine triphosphate (ATP) in the mitochondria otherwise named the 
“fuel” of the cells is observed (Convissor 2016). Reactive oxygen species 
(ROS) are generated in the TMJ by straight mechanistic injury, hypoxia-
reperfusion, and arachidonic acid catabolism to the articular tissues.  Stress 
loading of TMJ produces an amplified group of free radicals, biosynthesis of 
arachidonic acid catabolite, discharge of neuropeptide and cytokines; and 
instigation of matrix damaging enzymes (Nitzan, 2001). 
The arachidonic acid catabolism produces Prostaglandin E2 (PGE2) and 
Leukotriene B4 (LTB4) in the articular tissues and excites mast cells and 
14 
 
leukocytes. Further on, this produces a diversity of propagators of 
inflammation, cytokines and free radicals.  Also, change in SF viscosity in 
TMJ is a result of ROS produced by reduced depolymerization and/or 
molecular configuration of hyaluronic acid. The decline in the surface-active 
phospholipid layer is an example of the production of ROS, leading to a 
decrease in lubrication of the articular surfaces of TMJ. 
In addition, breakdown of collagen proteoglycans and triggering of cartilage 
damaging enzymes are possible results of ROS formation. These markers 
are participants of lipid peroxidation and the disruption of cellular 
homeostasis (Kawaia et al., 2008). Extra participants of ROS have been 
found in the TMD patient's synovial fluid: the cytokines, interleukin-1 (IL-1), 
interleukin-6 (IL-6), and tumour necrosis factor-α (TNF-α). The nitric oxide 
(NO) radical has the ability to inhibit the production of collagen and 
proteoglycan synthesis in chondrocytes (TMJ cells) (Tomida et al., 2003). 
Hence, alternative therapies using photobiomodulation can offer better 
treatment for TMD patients. 
2.5.2 Photobiomodulation and inflammatory responses 
Photobiomodulation, over the last few decades, has been used for the 
treatment of musculoskeletal pains and inflammation (Hughes and Song, 
2016). An anti-inflammatory effect is urged by photobiomodulation through 
modifying transcription factors linked to Cyclooxygenase-2 (Cox-2). The 
photobiomodulation can modify the expression of proinflammatory 
messenger RNA (mRNAs). Also, decreased neutrophil influx and interleukin 
1 beta (IL-1β) mRNA expression is one of the effects of photobiomodulation 
(Bortone et al., 2008; Aimbire et al., 2008). The inhibition of PGE2 
production and decrease in Cox-2 mRNA levels are confirmed after 
application of photobiomodulation (Sakurai et al., 2000).  
A photobiomodulatory study (904 nm) in the presence of lipopolysaccharide 
(LPS) to encourage peritonitis in mice, reported a decrease in inflammatory 
cell movement (Correa et al., 2007). The application of photobiomodulation 
with 780 nm diode laser, at an energy dose of 7.7 J/cm2, reduced the 
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expression of IL-6, COX-2. This study reported decreased transforming 
growth factor-beta (TGF-β) that has been linked to collagenase-induced 
tendinitis (Pires et al., 2011). Moreover, photobiomodulation with 660 nm 
wavelength decreased the manifestation of nitric oxide (NO) (Boschi et al., 
2008). The decrease in IL-6, monocyte chemoattractant protein 1 (MCP-1), 
IL- 10, and tumour necrosis factor-alpha (TNFα) were confirmed after 
photobiomodulation with 660 nm wavelength (Boschi et al., 2008). 
Furthermore, photobiomodulation repressed the mRNA expression of pro-
inflammatory cytokines (Cox-2, IL-1, IL-6, and IL-8) and released proteins 
(IL-6 and IL-8), confirming an anti-inflammatory effect with hADSCs. The 
nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kB) is a 
vital transcription factor involved in the regulation of inflammation. The 
suppression of pro-inflammatory cytokine expression is another finding of 
the effect of photobiomodulation (Akira and Takeda, 2004). Transcriptional 
activity of NF-kB was also subdued by photobiomodulation significantly (660 
nm laser at a fluence of 7.5 J/cm2) indicating that the anti-inflammatory 
effect of photobiomodulation can be mediated by NF-kB (Aimbire et al., 
2008). Besides, photobiomodulation halts the inflammatory activity through 
inhibition of NF-kB transcriptional activity. 
Photobiomodulation increases the intracellular levels of cyclic adenosine 
monophosphate (cAMP). The cAMP is an important second messenger in 
many biological processes, such as cell proliferation, differentiation, 
apoptosis, and inflammation (Zungu et al., 2009; Karu et al., 1985).  The 
use of 904 nm at an energy density of 5 J/cm2 was able to halt the 
breakdown of IκBα (Rizzi et al., 2006). Also, the increase of intracellular 
cAMP levels constrains the transcriptional processes of NF-kB and the 
aptitude of cAMP. This is to manage IκB kinase (IKK) activity and IkB 
degradation in addition, to alter the structure of NFkB dimers and inhibit 
transcription (Gether 2000; Zhong et al., 1997; Parry et al., 1997; Gerlo et 






Figure 2.3. Proposed mechanism of action in Synovial fluid (SF), 
photobiomodulation encourages anti-inflammation through decreased 
neutrophil influx and IL-1b, inhibits production of PGE2, reduced the 
expression of pro-inflammatory cytokines (Cox-2, IL-1, IL-6, and IL-8), 
transcriptional activity of NF-kB is inhibited. The inflammatory precursors; 
arachidonic acid and matrix damage proteins are influenced by laser. 
Application of laser may help in the treatment of TMD. 
2.5.3 ADSCs and photobiomodulation as an alternative method of 
treatment for the TMJ disc 
Self-regeneration abilities have been found in stem cells and an ability to 
differentiate into cell varieties producing mature cells. The MSCs have a 
substantial function in tissue homeostasis that leads to tissue renewal. 
These pluripotent cells support hematopoietic and mesenchymal cell lines. 
Thus, they have been used as an attempt to produce therapeutic effects for 
TMD (Neel et al., 2014). The requirement for a stem cell is a capacity to self-
regenerate and to differentiate along multiple lineage pathways (Lanza 2009).  
Adipose Derived Stem Cells are part of MSCs lineages with many benefits. 
Researchers have offered several means through which ADSCs can be 
utilised to restore and renew tissues. The advantage of ADSCs is that when 
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they are placed thru unhealthy tissue, they secrete cytokines and growth 
factors that stimulate revival in a paracrine manner (Mazini 2019).  Adipose
Derived Stem Cells remove harmful constituents released by the ischemic 
place thru making available antioxidants chemicals, free radical scavengers, 
and chaperone/heat shock proteins.  These stem cells can be obtained in 
abundance from adipose tissue, resulting in a greater number of cells 
(Jeffrey et al., 2007). 
The combination of ADSCs and scaffolds to create adipose tissue has been 
suggested. Stem cell research was identified as minimally invasive 
therapies (Tsuji et al., 2014). Additionally, the cure for a wide variety of 
different degenerative disorders and diseases the injectable scaffolds have 
been offered (Tsuji et al., 2014). Some of these include clinical treatments 
of various bone, cartilage and musculoskeletal disorders, muscular 
dystrophies, cardiovascular and liver disorders. As per the reports, neuronal 
diseases and diabetes mellitus, the bioengineering of fat and 
musculoskeletal tissue reconstitution has benefited with this treatment 
modality (Tsuji et al., 2009; Mimeault et al., 2008). 
Research by Stancker et al. (2018) reported the intra-articular injection of 
ADSCs that stopped joint degeneration in the knee of the rat with induced 
osteoarthritis. Tissue engineering could provide new clinical treatment with 
the goal of producing de novo tissue in the TMJ disc (Serakinci et al., 2017). 
Tissue engineered implants are also offered as a possible clinical treatment 
of TMJ disc degenerative changes (Aryaei et al., 2016). 
2.5.4 Tissue engineering and photobiomodulation in TMJ disc therapy 
In medicine and dentistry, tissue engineering and photobiomodulation are 
progressing as new treatments for numerous diseases (Ensanya et al., 
2014; Khan and Arany, 2015). Tissue engineering has emerged as the 
future of treatment against degenerative changes in TMJ disc (Arany 2016 
a; Mehrotra 2013). A novel study regenerated damaged TMJ disc 
with/without biomolecules, scaffolds by transplantation process (Rahman et 
al., 2018). Photobiomodulation induced stem cell differentiation may provide 
18 
 
a new and progressive treatment option in dentistry. Moreover, the 
application of photobiomodulation to stem cell therapy in medicine has been 
progressing (Abrahamse 2011).  
A study used photobiomodulation on bone marrow (BM) to autologous BM 
to induce a patient’s own stem cells in the regeneration of the 
damaged/ischemic organ (Oron and Oron, 2015). Photobiomodulation with 
precise settings has been supported for the prevention of oral mucositis in 
cancer patients (Zadik et al., 2019). In clinical dentistry, photobiomodulation 
offers an opportunity to use regenerative options for the treatment of TMD 
(Carvalho et al., 2019). A sustainable therapy could be provided to patients 
with an improved quality of life (Sobral et al., 2018).  
Furthermore, a novel option of TMD treatment could be the scaffolds seeded 
with cells and cell injection (Donahue et al., 2019). Tissue engineering could 
offer better options; specifically, to regenerate and remodel the process of 
TMJ disc after injury (Lowe and Almarza, 2017). A valuable screening tool 
for potential tissue engineered solutions would be in vitro testing 
(Vapniarsky et al., 2018; Arany, 2016). A study pointed the possibility of 
adding chondrogenic and/or osteogenic cells to biomaterial scaffolds with 
the possibility of increasing the prospective for TMJ tissue regeneration 
(Helgeland et al., 2018).  The current study will be restricted to analyses of 
differentiation of ADSCs mediated by laser at two wavelengths for possible 
future tissue engineering application. 
2.6 Basic Fibroblast Growth Factor 
The bFGF used in this study is a growth factor and signalling protein 
encoded by the fibroblast growth factor 2 (FGF2) gene. The human genome 
contains one copy of the bFGF gene located on chromosome 4.  This growth 
factor is a recognised substantial mitogen for various cell categories and is 
discovered as a segment of basement membranes. Also, the bFGF is a part 
of the subendothelial extracellular matrix of blood vessels in natural tissue 
(Nukavarapu et al., 2015; Desai et al., 2014). The bFGF binds via specific 
fibroblast growth factor receptor (FGFR) proteins.  
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This growth factor initiates rapid neovascularization in the cornea, kidney 
capsule, or skin. Also, fibroplasia in the dermis is involved in neovascularization 
and wound repair (Rifkin and Moscatelli, 1989). The 10ng/ml dosage of bFGF 
was added to B and LB groups of ADSCs on the recommendation of a 
research study. Whereby this dosage of bFGF increased the thickness of 
urothelium with a reduction of inflammation in the radiation-induced endothelial 
dysfunctional urinary bladder (Zhang et al., 2015). 
2.7 CD26 (clone M-A261) 
Fibroblasts synthesize the extracellular matrix of connective tissue and play 
an essential role in maintaining the structural integrity of most tissues 
(Magnus et al., 2018). The Mouse anti Human CD26 antibody, clone M-
A261, recognizes human dipeptidyl peptidase 4 (DPP4). The CD26 is a 766 
amino acid ~110 kDa single pass type II transmembrane glycoprotein 
expressed by activated T cells, B cells and macrophages. Dipeptidyl 
peptidase 4 is expressed by microvascular endothelial cells in humans. 
Hence, due to constituents of TMJ disc the use of CD26 was appropriate for 
confirmation of laser induced differentiation of ADSCs to fibroblasts. 
2.8 CD49C (clone P1B5) 
A study that confirmed immunopositivity for CD49C and CD39 has 
demonstrated elevated levels of Sox-9, essential for differentiation of 
precursor cells into chondrocytes. (Garcia et al., 2016). The clone P1B5 
recognizes CD49C, mouse anti human CD49C antibody. It is a 150 kDa cell 
surface antigen which is also known as the alpha-3 integrin and as very late 
(activation) antigen 3 (VLA-3). The substantial levels of CD49C are 
expressed by epithelial cells and endothelial cells.  
Significantly higher levels in chondrocytes with higher chondrogenic 
capacity have been reported by the study using flow cytometry analysis for 
expression of CD49C. The CD49C expression indicator produced tissues 
with higher levels of glycosaminoglycan (GAG) per deoxyribonucleic acid 
(DNA) (up to 1.4-fold) and type II collagen mRNA (up to 3.4-fold). 
Furthermore, the high expression levels of these genes would increase the 
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tendency of the cells to differentiate and produce cartilage (Grogan SP et 
al., 2007). Hence, due to the constitution of the TMJ disc, the use of CD49C 
was suitable for the confirmation of laser induced differentiation of ADSCs 
to chondrocytes. 
2.9 Clinical Application of 660 nm and 940 nm Diode Lasers 
The application of photobiomodulation to stem cell therapy in medicine has 
been on increase (Abrahamse 2011). Likewise, the increase in muscle 
regeneration with an application of a 660 nm diode laser was observed on 
damaged skeletal muscle in rats (Rodrigues et al., 2013).  Another study 
reported an improvement in muscle regeneration of an injured 
sternomastoid muscle generated by bupivacaine after the application of a 
660 nm diode laser (Pissulin et al., 2017). However, the application of 940
nm laser in different areas of dentistry is gaining more interest. The research 
study has tested the adherence of dental adhesive to dentin after irradiation 
with 940 nm diode laser reporting a stronger bond (Kasraei et al., 2019).  
The application of a 940 nm diode laser has been used as a safe and 
effective tool in the management of tongue abscess (Tewari et al., 2018). In 
vitro study reports 940 nm diode laser as an effective treatment for herpes 
simplex virus (Namvar et al., 2019). Additionally, a study has reported that 
940 nm diode laser increased the levels of interleukin-1β (IL-1β) (powerful 
pro-inflammatory cytokine) in gingival crevicular fluid and accelerated 
orthodontic tooth movement (Varella et al., 2018). The interleukin-6 (IL-6), 
cytokines, interleukin-1 (IL-1), and tumour necrosis factor-α (TNF-α) have 
been participating in destructive processes of TMJ SF (Tomida et al., 2003).  
Further on, significantly reduced pain in patients have been reported with 
940 nm diode laser after undisplaced flap surgery and a decrease in 
postoperative trismus and swelling (Heidari et al., 2018; Eroglu and Keskin 
Tunc, 2011). The studies that used 940 nm diode laser and 2780 nm Er, Cr: 
YSGG have eliminated the Enterococcus faecalis (E. faecalis) in root 
infection (Tilakchand et al., 2018; Schulte-Lünzum et al., 2017; Gutknecht 
et al., 2016). Another study reported the proliferation of fibroblasts that 
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applied 940 nm diode laser (Illescas-Montes et al., 2017). However, the 
laser parameter’s, dosage and time of exposure differ from study to study. 
The current study will address this issue by application of a specific laser 
parameter, dosage, and time of exposure.  Furthermore, supported by 
literature data collected from previous studies, this study will explore 
photobiomodulatory effects of 660 nm and 940 nm diode lasers on ADSCs 
at 5 J/cm2 fluence in experiments at different time intervals. The study will 
explore the potential future replacement of damaged TMJ disc cells (two 
thirds fibroblasts and one third chondrocytes) with fibroblasts and 
chondrocytes differentiated from ADSCs using laser irradiation (660 nm, 


























All postulated research questions of this study are answered sufficiently with 
a wide variety of experiments that were managed in a systematic manner. 
A workflow that summarizes this study is provided in appendix A. Appendix 
E contains all the consumables used in this study. Appendix F is a list of all 
chemicals, reagents and media used in this study. All formulas, 
measurements and calculations used in the course of the investigation are 
provided in Appendix G. The equipment used in individual sections of the 
study is listed in Appendix H.  
The ethical approval letter that was granted by the Ethics Committee of the 
Faculty of Health Sciences, University of Johannesburg in accordance with 
the Human Tissue Act 65, 1983 is provided as Appendix C. All experiments 
were conducted in sterile conditions using a type II biosafety cabinet, (Figure 
3.1 A), following standard techniques and Good Laboratory Practices (GLP) 
guidelines. The biosafety cabinet when not in use was exposed to UV light, 
(Figure 3.1 B). The irradiation on cells was performed in a dark room and 
using protective clothing and glasses. Laser safety regulations of South 
Africa and European Union were followed.  
  
Figure 3.1. A. The biosafety cabinet (Airvolution) in the Stem Cell Lab at 
the Laser Research Centre, University of Johannesburg. B.  The biosafety 





3.1 Study Design Sample Collection  
This research was an experimental study using immortal ADSCs and all 
experiments were done in vitro. The ADSCs purchased from ATCC were 
used (ATCC Cat # SCRC4000™, ASC52telo (Lot # 70003596). The 
Academic Ethics Committee of the Faculty of Health Sciences, University of 
Johannesburg approved this study, with clearance number REC-241112-
035. The ADSCs were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM, Sigma Life Science, D5796) supplemented with 10% foetal bovine 
serum (FBS, Gibco TM 10270 106), 1% penicillin/streptomycin (Sigma Life 
Science, P4333), 1% Amphotericin B, (Sigma Life Science, A2942) (Zuk et 
al. 2001). The stem cell cultures were incubated at 37°C in an atmosphere 
of 5% carbon dioxide (CO2).  
3.2 Cell Seeding Optimization 
Cells from a confluent flask were trypsinazed with TrypLE™ Select (Gibco® 
12553-029) and quantified using an automated cell counter (Invitrogen 
Countess™ II FL); and the viable cell number was quantified for seeding 
calculations. The TrypLE™ contains purified, recombinant cell-dissociation 
enzymes that was used for the dissociation of adherent cells (Appendix D). 
Cells with TrypLE™ were detached without force, by placing the flask in the 
incubator for 3-5 min. A sterile pipette was used to aspirate detached 
ADSCs into a 50 ml falcon tube (Beckson Dickinson). The flask was rinsed 
twice with pre-warmed Hanks Balanced Salt Solution (HBSS) (Sigma 
Aldrich) to collect all the cells and were dispensed into the 50 ml tube.  
After this stage, the cells were centrifuged at 2,200 rpm for 5 min. The 
supernatant was discarded into a waste bottle and the cells were re-
suspended in 5 ml of pre-warmed complete medium. The experimental 
groups include cells observed at 24, 48 and 72 h; and at 1-week and 2, 3 
weeks. The seeding densities were optimized for the experiment to reach 
ideal cell confluence (not more than 90%). Cells were seeded at varying 
concentrations of 3 x 105, 5 x105, 1 x104 and 5x103, 1x 105, separately in 
3.4cm plate, and incubated as described (Table 3.1).  
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The cells were checked for attachment at 24, 48, 72 h and 1-week; and at 
2, 3-weeks of incubation using inverted light microscope (Wirsam, Olympus 
CKX41) fitted to an Olympus C5060-ADUS camera, analysed using Getit 
software (Figure 3.2).  
 
Figure 3.2. Olympus CKX41 inverted light microscope used for visualization 
and assessment of cell morphology (Wirsam, Johannesburg, South Africa). 
The pre-warmed complete media was added to ADSCs and the cells were 
placed back in the incubator. The cells were observed at 24, 48, 72 h and 
1-week; and at 2,3-weeks for morphological changes and growth; 
confluence and quality of media. Additionally, visual observation was 
performed after the media change. The media was removed and replaced 






Table 3.1. The optimization of ADSC seeding density. 
 
3.3. Laser irradiation and Basic Fibroblast Growth Factor Induced 
Differentiation of ADSC  
3.3.1 Differentiation of ADSCs to fibroblasts and chondrocytes  
The identity and characterization of ADSCs was established before seeding. 
The ADSCs were grown in a 175 cm2 flask and collected at 90% confluence. 
Pre-warmed HBSS, 5 ml, was used to wash the attached cells to remove 
traces of the medium. To detach the cells, 5 ml of pre-warmed TrypLE™, 
was added into the T175 culture flask, a sterile pipette was used to aspirate 
detached ADSCs into a 50 ml falcon tube (Beckson Dickinson). Then the 
cells were centrifuged at 2,200 rpm for 5 min. The supernatant was 
discarded into a waste bottle and the cells were re-suspended in 5 ml of pre-
warmed complete medium in a 50 ml falcon tube (Beckson Dickinson).  
The cells were seeded in culture plates for further experiments, grouped 
into, Group 1 (C) was a group of ADSCs with no laser irradiation and bFGF 
(Sigma Aldrich, Merck Group, South Africa, GF003). Group 2 (LB) with laser 
irradiation and bFGF added before irradiation. Group 3 (B) with no 
irradiation and bFGF alone, and ADSCs irradiated with laser only, group 4 
(L). Growth factor, bFGF was added to the ADSCs at the recommended 
dosage of 10 ng/ml (Zhang et al., 2015). The bFGF is a recognised sturdy 
mitogen for many cell’ categories (Nukavarapu et al., 2015; Desai et al., 
2014; Zhang et al., 2015).  
            Time period Number of cells 
24-hours post-irradiation group 5 x 105 
48-hours post-irradiation group 3 x 105 
72-hours post-irradiation group 3 x 105 
1-week post-irradiation group 1 x 104 
2-weeks post-irradiation group 5 x 103 
3-weeks post-irradiation group 5 x 103 
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The ADSCs (irradiated and non-irradiated) were re-incubated at 37°C in a 
humidified atmosphere of 5% CO2. The irradiation of ADSCs was done with 
660 nm diode laser with a continuous wave (RGBlase LLC, Fremont, CA, 
USA, TECIRL-100G- 650SMA), supplied and established up by the National 
Laser Centre (NLC) of the Council for Scientific and Industrial Research 
(CSIR), South Africa. The irradiated and non-irradiated samples were re-
incubated at 37°C in an 85% humidified atmosphere of 5% CO2, (Figure 
3.3). 
Figure 3.3. The incubator (HERA cell 150i) used for cultivating cell, in vitro 
(TermoFisher scientific, Johannesburg, South Africa). 
The Field Mate Laser Power Meter (Field Mate, Coherent, Power Sens 
detector (0496005)) was used to read the power output. To estimate the 
time of exposure for different irradiation experimental groups, the power 










All the laser parameters for 660 nm diode laser were recorded, (Table 3.2.) 
Figure 3.4A represents the image of 660 nm diode laser used for 
experiments. 







Laser type Semiconductor diode 
Wavelength 660 nm 
Wave emission Continuous 
Spot size 9.1 cm2 
Output power (mW) 24, 48 and 72 hours –      97,1 
1 week and 2, 3 weeks – 98,25 
Power density 
(mW / cm2) 
24, 48 and 72 hours –      10,6 
1 week and 2, 3 weeks – 10,8 
Fluencies 5 J/cm2 
Irradiation times  
calculated with 
reading of power output 
24, 48 and 72 hours –      7.48 min  



















Figure 3.4. A- The 660 nm diode laser. B - Epic X, 940 nm diode laser. The 
940 nm diode laser is invisible light. The red light appearing in the image is 
guiding light. 
In another experimental set, irradiation was done by 940 nm, indium gallium 
arsenide phosphide (InGaAlP Semi-conductor) diode laser (Biolase, 
Science vision, USA), class IV; with guided red light at output of 1 mW. The 
ADSCs were irradiated at 5 J/cm2 fluence via TMJ handpiece at CW, in the 
dark environment from above without a lid of 3.4 cm diameter plate. The 
exposure time (3 sec) was set automatically at the desired fluence. The 
power output was set at 1.4 W for all experiments, (Figure 3.4B). All the 
laser parameters for 940 nm diode laser were recorded, (Table 3.3). 
Table 3.3. Laser parameters for 940 nm diode laser. 
Laser type   InGaAsP Semi-conductor 
Wavelength   940 nm  
Wave emission   Continuous 
Spot size           9.1 cm2 
Output power     24,48 and 72 h; and 1- week and 2, 3 weeks = 
1.4 W 
Power density (mW / 
cm 2) 
24,48 and 72 hours; and 1- week and 2, 3 
weeks=153.84  
Fluencies 5 J/cm 2 






3.3.2 Morphology and trypan blue exclusion assay 
An inverted light microscope was used to evaluate the morphology of cells 
at 24, 48, 72 h and 1, 2 and 3-weeks post–irradiation with 660 nm and 940
nm diode lasers in separate experiments. Trypan blue viability assay 
(Sigma‐Aldrich, Johannesburg, South Africa, T8154) was used to quantify 
live and dead cells in experimental groups. This trypan blue chromophores 
are negatively charged reacting only to lifeless cells compromised 
membranes, resulting in stainless and colourless viable cells (Phillips and 
Terrberry, 1957). In this study, equivalent measurements of cells and trypan 
blue (10 μl) were mixed by pipetting. The percentages of cell viability were
read using the Countess cell counter.  
3.3.3 ATP proliferation 
The quantity of viable cells in the stem cell culture irradiated with 660nm 
and 940 nm diode lasers in separate experiments was established using the 
luminescent cell viability assay CellTiter-Glo® 3D (Promega). The quantity 
of intracellular ATP was measured. The ATP proliferation is an indicator of 
the mitochondrial activity quantifying the presence of energy-storing active 
cells (Hodgkinson et al., 2017; Crous et al., 2019). The luminescence is 
produced by change in ATP to adenosine monophosphate (AMP) by the 
enzyme luciferase.  
To measure the ATP proliferation, equal volumes of cells and reagent (50 
μl) were added to a white-walled luminescent 96 well plate (BD Biosciences, 
353, 296) and mixed for 5 min on a shaker to incite cell lysis. Thereafter, the 
cells were incubated in dark for 25 min at room temperature. Background 
wells were maintained for each experimental group.  The luminescence was 
read for all wells in comparative light units (RLU) on the Victor 3 multiplate 
reader (Perkin-Elmer), (Figure 3.5). The ATP proliferation was determined 












Figure 3.5.  The spectrophotometer (Victor 3) (Midrand, Johannesburg, 
South Africa) used for measuring luminescence for ATP assays.  
3.3.4 Flow cytometry analysis 
Before using Accuri C6 flow cytometer for all experiments, quality control 
(QC) was performed using the BD Accuri™ Spherotech-8-peak validation 
beads (Cat.No.653144) and 6-peak validation beads (Cat.No.6531450). 
The BD Accuri™ Spherotech 8-peak validation beads are used to validate 
the performance of the FL1 (FITC-green), FL2 (PE-orange), and FL3 (PE-
Cy™5–dark red) detectors, while the BD Accuri™ Spherotech-6-peak 
validation beads are used to validate the performance of the FL4(APC) 
detector. The flow cytometry tubes were loaded on the analyser set to 
capture 10000 events in 250 µl at medium speed. The distillate water was 
read to confirm the purity of the reading.  
Indirect flow cytometry protocol was applied to determine the percentage of 
differentiation of ADSCs into fibroblasts and chondrocytes. The 
differentiated percentage of ADSCs into fibroblasts, and chondrocytes was 
determined with the 660 nm and 940 nm diode lasers and at 1- and 2-weeks 
post-irradiation in separate experiments. The ADSCs were stained with
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fluorescent mouse anti-human CD26 (clone M-A261) antibody marker (Bio 
Red Laboratories (Pty) Ltd, South Africa) that was used to identify fibroblast 
in all experimental groups except control. Additionally, the CD49C (clone 
P1B5) antibody marker (Bio Red Laboratories (Pty) Ltd, South Africa) was 
used to identify chondrocytes in L group.  
The cells were stained with CD26 (clone M-A261, mouse anti-human, Bio 
Red Laboratories (Pty) Ltd, South Africa) at 1: 100 μl in PBS; in all 
experimental groups. Further on, the expression of CD49C (clone P1B5, 
mouse anti-human, Bio Red Laboratories (Pty) Ltd, South Africa) was 
checked at 1: 200 μl in PBS in C and L groups. After 1-week and 2-weeks 
of experimental culture conditions, cells were washed and trypsinazed. In 
the next stage the cells were centrifuged at 400 g for 5 min at room
temperature. The cell pellets were resuspended in 1 ml PBS (Sigma, A2153 
(Sigma, S8032) and the automated cell counter was used to establish a 
number of cells and viability.  Thereafter, 1x106 cells were added into the 
focus tube in 100 μl of cold (4°C) PBS followed by 10 μl of primary antibody. 
The incubation of cells was done in dark for 30 min and washed thereafter 
with PBS three times. The cells were then centrifuged at 400 g for 5 min at 
room temperature. Ten microliters of the secondary antibody per 1x106 cells 
(FITC-Goat-anti-Mouse (Biotechnology) were added into already prepared 
100 μl PBS, followed by vortexing of cells.  
The cells were resuspended again in PBS for the immediate flow cytometry 
reading. The samples irradiated with 660 nm and 940 nm diode laser were 
read at 10000 events at 1-week and 20000 events at 2-weeks post-






Figure 3.6. The Flow Cytometer (BD Accuri C6) (Bio-Rad, Johannesburg, 
South Africa) instrument used for fluorescent characterization of cells. 
Further on, 10000 events were read for C and L groups to record the 
expression of CD49C marker. The Accuri C6 flow cytometer (BD 
Biosciences) was used for detecting the fluorescence (dye-stained cells) 
immediately compared to gated control (unlabelled ADSCs) (Figure 3.6).  
The ADSCs labelled with CD26 and CD49C markers were tagged with FITC 
– green. The fluorescence reading was done with a 533/30 filter and 488 
nm laser, applying FL-1.  The results were gated based on forward scatter 
(FSC), side scatter (SSC), total count, and fluorescence; and saved on the 
computer. 
3.3.5 Immunofluorescence 
The methods of immunofluorescence that are recognized are direct, indirect 
and complement binding (Coons et al., 1941; Mohan et al., 2008). In this 
study, all experiments were done with 660 nm and 940 nm diode laser in 
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separate experiments. The indirect immunofluorescence protocol was used 
to detect the differentiation of ADSCs to fibroblasts in C, LB, B and L groups; 
and for the chondrocytes at 1-week and 2-weeks post-irradiation for L group.  
The ADSCs were labelled with a primary antibody and made observable 
using fluorochromes attached to secondary antibodies. The ADSCs were 
cultured on coverslips that were heat sterilized and placed in 3.4 cm 
diameter culture dish with 2 ml of complete media at a concentration of 1 X 
104 for 1-week and 5 X 103 per plate for 2-weeks post irradiation observation 
experiments. Cells were incubated and allowed to attach to the coverslip. 
The attached cells were then irradiated with 660 nm and 940 nm diode laser 
in separate experiments and cultured for a duration of 1-week and 2-weeks 
post irradiation.  
Thereafter, in separate experiments the cells were rinsed three times using 
PBS (Sigma, A2153 (Sigma, S8032), and allowed to fix in dark (4% 
Paraformaldehyde) (Sigma, P6148) for 15 min. In the next stage, blocking 
buffer (10 % (w/v) BSA (bovine serum albumin) was added to cells and 
incubated for 30 min at room temperature and washed three times using 
PBS. The cells were then incubated with 100 μl primary antibody CD26 
(1:100 μl in PBS) for 1 h without light and washed three times with washing 
buffer after incubation.  
Cells were then labelled and incubated with 100 μl of the secondary 
fluorescent FITC Goat anti-Mouse antibody at 1:100 μl in PBS for 1 h in 
dark. In another set of experiment, the cells were incubated in dark with 100 
μl of CD49C (1: 200 μl in PBS) after blocking; and rinsed three times with 
PBS after incubation. Then, the cells were incubated with 100 μl of the 
secondary fluorescent FITC Goat anti-Mouse antibody at 1:100 μl in PBS 
for 1 h in dark. In the final stage, the cells were rinsed once with PBS, before 
staining by 4’- 6- diamidino-2-phenylindole (DAPI) ((Invitrogen™, D1306) 
358Ex/461Em). and mounted on heat sterilised glass slides using 
Fluoromount™ Aqueous Mounting Medium (Sigma, F4680). DAPI was used 
to counterstain nucleus. The Carl Zeiss Axio Z1 Observer, fluorescent 
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microscope using AxioVision imaging software (Carl Zeiss, Randburg, 
Johannesburg, South Africa) was used for viewing of slides using at 200x 
magnification, (Figure 3.7).   
3.4 Statistical Analyses 
Statistical analysis was performed using Sigma Plot software version 13.0. 
One-tailed student t-test was performed to compare the untreated control 
and experimental groups, within the group time intervals for each 
independent variable (viability, proliferation, flow cytometry). All individual 
sets of experiments were repeated three times. The levels of significance 
used to analyse were * p< 0,05, ** p< 0,01, *** p< 0,001. All plotted graphs 
had the standard error represented by error bars, respectively. 
 
Figure 3.7. The Carl Zeiss Axio Z1 microscope (Carl Zeiss, Randburg, 








The ADSCs were cultured in DMEM supplemented with 10% FBS, 1% 
penicillin/streptomycin, 1% Amphotericin B and incubated at 37°C in an 
atmosphere of 5% carbon dioxide (CO2). The overgrowth, and amplified cell 
death with increasing time of cultivation was observed with our bid to 
observe the cells with similar seeding densities. Hence, different seeding 
densities was required to avoid the above-mentioned faults and to detect 
appropriate results beyond 72 h. The ADSCs were irradiated with 660 nm 
and 940 nm diode lasers and with/without bFGF and compared to control 
groups within each time interval at 24,48 and 72 h; and 1-week and 2,3-
weeks in the separate experiments. The ADSCs differentiation to fibroblasts 
and chondrocytes was confirmed through flow cytometry and 
immunofluorescent analyses at 1-week and 2-weeks post irradiation using 
CD26 for fibroblasts and CD49C for chondrocytes. 
4.1 Results for 660 nm and 940 nm Diode Laser Experiments  
4.1.1 Cell morphology and viability 
Cellular proliferation was evident in morphological images for 660 nm diode 
laser at 24, 72 h and 1-week post-irradiation, (Figure 4.1). Figure 4.2 
represents image at 24, 48 h and 1-week groups post-irradiation with 940 
nm diode laser. Cellular morphology and confluence at 2 and 3-weeks were 
similar to that observed at 1-week for both wavelengths. In the control, a 
reduction in proliferation was observed at 1-week and 2, 3-weeks. However, 
the proliferation was confirmed beyond 72 h in all experimental groups with 
laser irradiation and bFGF.  
Cellular viability was recorded above 90% in all experimental groups post-
irradiation with 660 nm and 940 nm diode laser. In L group at 72 h a
statistical significance of p< 0.05 was recorded compared to the control 
group post-irradiation with 660 nm diode laser, (Figure 4.3). However, for 
940 nm diode laser statistical significance of p< 0.05 was recorded in L 





Figure 4.1. Cellular morphology of ADSCs assessed at 24, 72h and 1-week 
post-irradiation with 660 nm diode laser.  All cells appear viable and healthy 
with definitive spindle shaped morphology. At 72 h, ADSCs in all the groups 
showed increased proliferation of cells. At 1-week, a decline in the 
proliferation of ADSCs in the control group (0 J/cm2 and no bFGF) can be 
seen, compared to other experimental groups. The effect of laser and bFGF 






Figure 4.2. Cellular morphology of ADSCs assessed at 24, 48 h and 1-week 
post-irradiation with 940 nm diode laser. The cells appear viable and have 







Figure 4.3. Viability ADSCs assessed with trypan blue at different time-
intervals post-irradiation with 660 nm diode laser and bFGF. The viability 
recorded above 90% in all experimental groups of cells. The only statistical 
significance was recorded at L72 h (p< 0.05). The statistical significance is 
presented as * p < 0.05.  
 
Figure 4.4. Post irradiation viability assessment of ADSCs using trypan blue 
at different time-intervals with 940 nm diode laser. The only statistical 
significance (p< 0.05) recorded with student’s one tail t-test was recorded at 
2-weeks, in laser treated group. The statistical significance is presented as 
* p < 0.05. 
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4.1.2 ATP proliferation 
The ATP proliferation of treatment groups was contrasted to their respective 
controls in the same time interval due to different seeding densities. A
significant increase in ATP was recorded in the L and B group at 1-week; 
and in LB group at 72 h post-irradiation with 660 nm diode laser. While at 
48 h, the highest ATP proliferation was recorded in group L with the same 
wavelength. The proliferation of ATP at 24 h post-irradiation was statistically 
insignificance compared to other groups (Figure 4.5). At same time intervals 
with 940 nm diode laser, an increase in ATP was recorded only in the LB 
group at 72 h post-irradiation. With 940 nm diode laser, proliferation of 
ADSCs is more rapid than with 660 nm diode laser (Figure 4.6). 
At 2-and 3-weeks post-irradiation with 660 nm diode laser, no statistical 
significance was recorded. The ATP proliferation with 940 nm diode laser 
had no statistical significance at 1- and 2,3-weeks (Figure 4.6). Hence, it 
appears that the lasers used in this study have different effect in ATP 
proliferation of the cells.  
Figure 4.5. Cellular ATP proliferation assessed at 24,48 and 72 h; and 1-
week post-irradiation with 660 nm diode laser. The ATP proliferation was 
evident in all irradiated groups of cells with and without bFGF compared to 
control cells. The result represents the substantial role of bFGF and laser in 
cell proliferation and an increase in ATP. As represented, at 72 h, cells in the 
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treatment group showed a significant increase in ATP compared to cells in 
other groups. The statistical significance is presented as * p < 0.05, ** and p < 
0.01. 
 
Figure 4.6. Cellular ATP proliferation assessed at 24,48 and 72 h; and 1-
week and 2,3 weeks post-irradiation with 940 nm diode laser. The ATP 
proliferation was evident in all experimental groups of ADSCs related to 
control groups of cells. The importance of bFGF and laser in cell proliferation 
and an increase in ATP is clearly reflected. A significant increase in ATP 
compared to cells in other groups is evident at LB72 h. The statistical 
significance is presented as * p < 0.05.
4.1.3 Flow cytometry analyses 
In the experimental groups up to 72 h and at week 3 the differentiation and 
expression of markers appeared minimal post–irradiation with 660 nm and 
940 nm diode lasers. Therefore, the outcomes presented are at weeks 1 
and 2. The expression of CD26 marker for fibroblasts was confirmed in LB, 
B, and L groups at 1-week and 2-weeks post-irradiation for both 
wavelengths. The experimental groups were compared to a group of ADSCs 
that had no markers, and no bFGF added and 0 J/cm2 (control group). The 
highest percentage of CD26 expression (mean value 28.27%) was 
documented at 1-week and 2-weeks (mean value 25.37%) post-irradiation 
with 660 nm diode laser in group LB, (Table 4.1).  
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The percentage of CD26 marker recorded at 1-weeks post-irradiation with 
940 nm diode laser had statistical significance in all experimental groups. 
However, with 940 nm diode laser at 2-weeks post-irradiation, the results 
differ from 660 nm diode laser at same time interval. The only statistical 
significance and the highest percentage expression of CD26 was recorded 
in L group and with mean value of 45.00%, (Table 4.2). Additionally, the 
CD49C marker expression for chondrocytes was greater in L group, at 1-
week (mean value 19.13%) than 2-weeks (mean value 1.23%) post-
irradiation with 660 nm diode laser, (Table 4.1).  
In addition, at same time intervals the expression of CD49C marker for 
chondrocytes post-irradiation with 940 nm diode laser differs and was higher 
in L group, at 2-weeks (mean value 38.03%) than 1-week (mean value 
13.20%), (Table 4.2).These results indicate the difference in differentiation 
of ADSCs with two wavelengths at different time intervals. The figures 4.7A, 
B; 4.8A, B; 4.9A, B; and 4.10A, B characterize the best variable group of 
differentiation percentage post-irradiation using 660 nm and 940 nm diode 
lasers. The table 4.1 and 4.2 represent mean differentiation percentages of 
all experimental groups post-irradiation with 660 nm and 940 nm diode laser 
at different time intervals. 
Table 4.1. Flow cytometry experimental groups treated with 660 nm diode 
laser  
Flow cytometry experimental groups 
     B LB L 
CD26 at 1-week 
post-irradiation 
    23.46% ± 9.1** 28.27% ± 3.6 ** 
 
21.63% ± 0.7 ** 
CD26 at 2-weeks 
post-irradiation 
    10.80%± 0.2** 
 
25.37% ± 3.0 *** 
 




  19.13% ± 2.96  
 
CD49C at  
2-weeks 
post-irradiation 




The experimental groups of cells are labelled as follows: C - control, LB - 
laser and b FGF, B - b FGF and L - laser. The statistical significance is 
presented as * p < 0.05, ** p < 0.01, and *** p < 0.001; standard error of the 
mean (SEM) compared to control cells with no irradiation and bFGF added 
within the same time interval. The results represent mean values 
percentages with ± standard error of the mean (SEM). 
Table 4.2. Flow cytometry experimental groups treated with 940 nm diode 
laser  
Flow cytometry experimental groups 
     B LB L 
CD26 at 1-week 
post-irradiation 
   8.97 % ± 2.08**  16.57 % ± 2.8 ** 
 
8.67 % ±   2.2 *
CD26 at 2-weeks 
post-irradiation 
   19.20% ± 9.58 
 
20.83% ± 12.3 
 








  38.03 % ± 0.0  
 
The experimental groups of cells are labelled as follows: C - control, LB - 
laser and bFGF, B - bFGF and L - laser. The statistical significance is 
presented as * p < 0.05, ** p < 0.01, and *** p < 0.001; standard error of the 
mean (SEM) compared to control cells with no irradiation and bFGF added 
within the same time interval. The results represent mean values 
percentages with ± standard error of the mean (SEM) 
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Figure 4.7. Flow cytometry results presenting CD26 marker with positive 
expression with 660 nm diode laser. (A) The expression of CD26 in all 
experimental groups at 1-week post-irradiation showing percentages of 
differentiation.  The highest percentage of expression is observed in B group 
at 1-week and (B) at 2-weeks post-irradiation LB had the highest expression 











Figure 4.8. Positive expression of CD26 presented by flow cytometry with 
940 nm diode laser. (A) Expression of CD26 at 1-week post-irradiation
presenting percentages of differentiation in all experimental groups. The 
percentage of expression was higher in LB group at 1-week and (B) at 2-
weeks post-irradiation and group L had the highest expression of CD26 
marker related to the control group with no markers added.  
 
 
Figure 4.9. Positive expression of CD49C marker recorded with flow 
cytometry with 660 nm diode laser. The expression of CD49C marker 
increased at 1-week post-irradiation, (A) than at 2- weeks’ post-irradiation, 




Figure 4.10. Positive expression of CD49C marker recorded with flow 
cytometry with 660 nm diode laser. The expression of CD49C marker was 
evident at 2-weeks’ post-irradiation, (B) than at 1-week post-irradiation, (A) 
when compared to control groups (no irradiation and no markers added).  
4.1.4 Immunofluorescence 
In the immunofluorescence part of the study, minor(insignificant) differentiation 
pattern was noted in all groups as in flow cytometry analyses except for 1-week 
and 2-weeks post irradiation. Hence, the immunofluorescence confirmed the 
differentiation of ADSCs to fibroblasts and the expression of CD26 marker in 
all the experimental groups (LB, B, L) at 1-week and 2-weeks post-irradiation 
with 660 nm and 940 nm diode lasers. The fluorescent signals for CD26 marker
were high in the L group post-irradiation with 660 nm diode laser in Figures 
4.11A and 4.11B; and Figures 4.13A and 4.13B with 940 nm diode laser. 
At 2-weeks’ time interval after irradiation with 940 nm diode laser, irregular 
cell morphology of fibroblasts was noticed. However, the image presenting 
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post-irradiation result for 660 nm diode laser had regular morphology. 
Furthermore, the differentiation of ADSCs to chondrocytes (CD49C) was 
confirmed at 1-week and 2-weeks post-irradiation with 660 nm diode laser 
in group L, (Figure 4.12A, 4.12B). Nevertheless, the image representing the 
expression of CD49C marker at 2-weeks’ time interval with 660 nm diode
laser reports an irregular cell morphology. The CD49C marker expression 
and the differentiation of ADSCs to chondrocytes was confirmed at 1-week 
and 2-weeks’ time interval in group L for 940 nm diode laser, (Figure 4.14A 
and 4.14B).  
 
Figure 4.11. Differentiation of ADSCs to fibroblasts post-irradiation with 660 
nm diode laser confirmed by immunofluorescent microscopic images. The 
expression of CD26 in the figure represented by green fluorescence (FITC) 
as a confirmation of the differentiation of ADSCs to fibroblasts in group L at 
1-week (A) and 2 weeks (B) post-irradiation. The DAPI is represented in 
blue colour demarcating a cellular nucleus. The figure clearly confirms 




Figure 4.12. Differentiation of ADSCs to chondrocytes post-irradiation with 
660 nm diode laser confirmed by immunofluorescent microscopic 
images.The green fluorescent stain (FITC) representing the expression of 
CD49C, endorsing the differentiation of ADSCs to chondrocytes in group L 
at 1-week (A) post-irradiation. Nevertheless, the images captured at 2-
weeks (B) post-irradiation present the irregular cell morphology. The DAPI 










Figure 4.13. Differentiation of ADSCs to fibroblasts post-irradiation with 940 
nm diode laser confirmed through immunofluorescent microscopic images. 
The differentiation of ADSCs to fibroblasts in group L at 1-week (A) and 2 
weeks (B) post-irradiation presented as a green fluorescence (FITC) 
represents the expression of CD26. The nuclear counterstaining DAPI is 
represented in blue colour. The irregular morphology of fibroblasts can be 











Figure 4.14. Immunofluorescent microscopic images confirming the 
differentiation of ADSCs to chondrocytes post-irradiation with 940 nm diode 
laser. The green fluorescent stain (FITC) is presenting the expression of 
CD49C in images, endorsing the differentiation of ADSCs to chondrocytes 
in group L at 1-week (A) post-irradiation and at 2-weeks (B) post-irradiation. 
The chondrocytes morphology can also be clearly seen in the figure. The 









CHAPTER FIVE - DISCUSSION  
5.1 Discussion 
The treatment of degenerative changes of TMJ disc is difficult giving no 
permanent results. Consequently, the research studies have attempted to 
use biomaterial scaffolds and/or biomolecules with stem cells to shape new 
cells in the impaired TMJ disc (Mehrotra, 2013). The main characteristic of 
stem cells is the capacity to renew, a needed quality for tissue regeneration 
(Mäenpää et al., 2010). The ADSCs have capacity to renew and are a 
fragment of mesenchymal cell families. In addition, ADSCs release 
cytokines and growth factors to damaged tissue and it is encouraging revival 
in a paracrine manner (Mazini et al., 2019).  
Additionally, the ADSCs at the location without oxygen generate 
antioxidants and encourage the revival of the surviving cells (Jeffrey et al.,
2007). An in vitro study that used ADSCs with biodegradable polylactide 
discs (PLA) has established that this could be used for tissue engineering 
of the fibrocartilaginous in TMJ disc (Howell, 2003). The intra-articular 
injection of ADSCs and laser irradiation was reported to have barred knee 
joint deterioration with stimulated osteoarthritis (Stancker et al., 2018). In 
vitro studies have reported that ADSCs can differentiate into smooth 
muscles, bone, fat, cartilage and neural tissue (Rodriguez et al., 2006, 
Serakinci and Keith 2006). 
It has been postulated that the differentiated cells could be used to repair 
damaged tissues (Keith, 2006). Also, recent studies have indicated that 
irreversible stem cell therapy is becoming a reality (George et al., 2018; 
Coradeghini et al., 2010; Wang 2017; Ayuk et al., 2014). However, only a 
few studies have looked beyond 72 h post-irradiation (Hawkins-Evans and 
Abrahams, 2008; Evans and Abrahams, 2007). In this study, the effect of
laser irradiation with/without bFGF on the ADSCs was observed beyond 72 
h post-irradiation. To date, no research study reported the effect of 660 nm 




The present study reports the ATP proliferation and viability results beyond 
72 h. The intracellular ATP is a sign of the presence of the energy-storing 
cells and it is a direct indicator of cell proliferation (Hodgkinson et al., 2017; 
Crous et al., 2019). The upsurge in mitochondrial oxidative mechanism 
produced by respiratory chain components excitation will lead to an elevation 
of levels of the ATP in the mitochondria. The photobiomodulation exerts this 
effect on the cells (Karu, 2003). Hence, it is a confirmation of the importance 
of photobiomodulation in the generating of ATP in the cell (Karu, 2010). 
The ATP proliferation in this study was enhanced by irradiation with 660 nm 
and 940 nm diode lasers with/without bFGF added in separate experiments. 
Additionally, a high percentage of cellular viability was recorded in all 
experimental groups, post-irradiation at 5 J/cm2 fluence with both 
wavelengths. These results coinciding with the studies by Hawkans and 
Abrahamse (2005, 2006). They reported that lower fluence at 5 J/cm2 had a 
more positive effect on the cells than higher fluence (10 J/cm2). Another 
study reported that at 24 h and 48 h, diabetic wounded fibroblasts showed 
significant positive changes when irradiated (830 nm) at fluence of 5 J/cm2 
(Houreld et al., 2010).  
There was an evident increase in ATP proliferation of ADSCs in the current 
study at 24 h, 48 h and 72 h  after irradiation with 660 nm and 940 nm diode 
laser at 5 J/cm2 fluence. A similar result was recorded in a study that applied 
636 nm diode laser on ADSCs with 5 J/cm2 fluence (Mvula and Abrahamse, 
2014). A statistical significance was observed at 48 h post irradiation with 660 
nm in L group. This also signifies the photobiomodulatory effect beyond 48 h.  
At 72 h post irradiation  with 940 nm (p<0.05) and 660 nm (p<0.01) diode 
laser in the group with laser irradiation and bFGF added, the ATP 
luminescence was statistically significant. These results observed in LB 
group points to the importance of ATP proliferation at 72 h post irradiation. 
The relevance of these results can be seen in the differentiation of ADSCs 
to fibroblasts and chondrocytes at 1 week and 2 weeks where the 
proliferation gradually dropped. Additionally, at 72 h post irradiation with 660
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nm diode laser, the L and bFGF treated cells groups had statistical 
significance. Conversely, the 940 nm diode laser results had no statistical 
significance recorded in the same experimental groups.  
Also, a noticeable reduction in cell proliferation in groups with growth factor 
with both wavelengths was recorded in experimental groups at 24 h,48 h and 
72 h. This concurs with the results of a similar study that used 660 nm diode 
laser on fibroblasts at 5 J/cm2 fluence (Mokoena et al., 2019). Nevertheless, 
the group of ADSCs in L group at 24 h had the highest ATP proliferation result 
with 940 nm diode laser. The 660 nm diode laser in the same group has 
recorded the same result but at a different time interval (48 h). 
The outcome of the current study for 940 nm diode laser are different from 
the 660 nm diode results giving an indication of different rates of ATP 
proliferation between two wavelengths at the same time intervals. Similarly,
the ATP proliferation appears to be quantitively higher at 3-weeks after
irradiation than at 1- and 2-weeks post-irradiation with 940 nm diode laser 
experiments. Whereas, the experiments with 660 nm diode laser at same 
time intervals had almost even recording of ATP proliferation. There was no 
statistical significance recorded at these time intervals for 940 nm diode laser. 
Even though the ATP proliferation outcomes are different in all experimental 
groups, with high cell viability (above 90%), they give positive direction for 
future studies. For this reason, the current study results offer proof on the 
curative applications of 5 J/cm2 fluence with 660 nm and 940 nm diode 
lasers with/without added bFGF against degenerative TMJ disc disorder. 
Similar outcomes were conveyed in the research reports that had an 
increase in proliferation of cells, viability, and differentiation after 
photobiomodulation with diode lasers (980 nm, 660 nm) (Gholami et al., 
2020; Almeida-Junior et al. 2019; Jere et al. 2018). The current study 
outcomes indicate the signs of the relationship between ATP proliferation 
and cell viability and its importance in cellular differentiation. Moreover, this 
is reinforcing the importance of cellular viability and ATP proliferation 
measurements in experiments and at a fluence of 5 J/cm2.  
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Further on, the flow cytometry analyses, and immunofluorescence 
outcomes have confirmed differentiation of ADSCs to fibroblasts with both 
wavelengths and at 5 J/cm2 fluence. This was confirmed at 1-week and 2-
weeks time intervals in all experimental groups.  Equally, a differentiation 
prompted by laser was observed with ADSCs where at 5 J/cm2 fluence with 
636 nm differentiation was induced into smooth muscle cells (Mvula et al., 
2014). Another study had a similar effect (660 nm) with diabetic injured cells 
where the fibroblasts differentiated into myofibroblasts (Mokoeana et al., 
2019). In this study, the flow cytometry analyses result for fibroblasts with 
the  660 nm diode laser in B group had a statistical significance of p<0.01 
for both time intervals.    
At 1-week in group B, mean value was at 23.46% and at 2-weeks the mean 
value was at 10.80% with 660 nm diode laser experiments. Additionally, the 
results at 1-week for B group (8.97%) with a wavelength of 940 nm diode 
laser experiments testified the statistical significance of p<0.01 in the 
differentiation of ADSCs to fibroblasts. However, at 2-weeks with 940 nm 
diode laser experiments, the mean value was at 19.20% with bFGF alone 
with no statistical significance compared to their respective controls. At
same time intervals the elevated percentage of differentiation was also 
documented in LB group for both wavelengths. 
These results have specified promising possibility that the bFGF could 
enhance photobiomodulation effect and assist differentiation of ADSCs to 
fibroblasts. Similarly, the ADSCs differentiation to fibroblasts was confirmed 
with flow cytometry  with statistical significance at 2-weeks post-irradiation 
with 660 nm diode laser in all other experimental groups. At the same time 
interval with the 940 nm diode laser the differentiation of ADSCs to 
fibroblasts was also confirmed in all experimental groups. Nevertheless, the 
statistical significance was recorded only in L group due to high number of 
differentiated cells with 940 nm diode laser (45%) experiments. In L group 
the percentage of differentiation is less with 940 nm diode laser at 1-week 
post-irradiation compared to same time interval at 660 nm diode laser 
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results. The results have recorded the difference in differentiation of ADSCs 
into fibroblasts with two lasers in the L group. 
The flow cytometry result for LB group with 660 nm diode laser at 1-week 
post irradiation (28.27%) and at 2-weeks (25.37%) had statistical 
significance. This is an indication of higher differentiation of ADSCs to 
fibroblasts with 660 nm diode laser in LB group and at 1-week than at 2-
weeks post irradiation. The 940 nm diode laser had a higher differentiation 
of ADSCs into fibroblasts in the LB group at 2-weeks (no statistical 
significance) than at 1-week post-irradiation. The results are pointing to the 
difference in the differentiation of ADSCs into fibroblasts with two different 
lasers in the LB group. Also, the highest differentiation of ADSCs with 660 
nm diode laser was in the LB group at both time intervals comparing to other 
experimental results. 
The outcomes of the current study for flow cytometry analyses in the LB 
experimental group with 660 nm diode laser are an indication that bFGF and 
660 nm diode laser could differentiate ADSCs on their own. This conclusion 
of the current study can offer a promising opportunity for the replacement of 
the damaged TMJ disc cells. Conversely, the highest differentiation in the L 
group suggests the use of 940 nm laser alone in the application of ADSCs 
differentiation. On the other hand, the outcomes for both wavelengths could 
translate to the dual application of these lasers on ADSCs in inducing 
differentiation. 
Even though differentiation of ADSCs to fibroblasts was confirmed with 
immunofluorescence with both wavelengths the difference was observed at 
2-weeks’ time interval post irradiation with 940 nm diode laser where the 
irregular cell morphology of fibroblasts was captured in L group. The images 
for 660 nm diode laser had clear confirmatory morphology at 1-week and 2-
weeks post-irradiation. The results of immunofluorescence coincide with 
flow cytometry analyses results pointing again to the role of difference in 
time intervals and two wavelengths. 
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Once again, the outcomes of the current study give indication of possible
dual application of 940 nm and 660 nm diode laser. This can be done 
with/without bFGF at different time intervals as future management of 
degenerative TMJ disc. However, the bFGF was not used in the 
differentiation of ADSCs to chondrocytes and the effect of laser beam alone 
was observed. A study applied lasers (810 nm, 660 nm, 532 nm, 485 nm) 
on MSCs from rabbit iliac bone marrow to induce differentiation to bone or 
cartilage (Fekrazad et al., 2019).  
In the current study, the differentiation of ADSCs to chondrocytes was 
confirmed at 1-week and 2-weeks’ time intervals with flow cytometry 
analyses and subsequently with immunofluorescence. A study has reported 
a similar effect of photobiomodulation (405 nm) where the prechondrogenic 
ATDC5 (Mouse 129 teratocarcinoma AT805 derived) cells were 
differentiated into chondrocytes (Kushibiki et al., 2010). Comparing the 
results of flow cytometry analyses for both wavelengths, the percentage of 
chondrocytes is higher at 2-weeks post-irradiation (38.03%) with 940 nm 
diode laser. 
It is an indication that at this time interval 940 nm is much efficient in 
differentiating ADSCs to chondrocytes than 660 nm diode laser (1.23%). 
Also, with 660 nm diode laser at 1-week post irradiation, (19.13%) the 
percentage of differentiation to chondrocytes is higher than with 940 nm 
diode laser (13.20%). Hence, this is a clear indication of how laser 
wavelength and time interval can induce differentiation in ADSCs. 
In immunofluorescence results at 2-weeks’ time interval with 660 nm diode 
laser, the image recording expression of CD49C marker has shown an
irregular cell morphology. At the same time interval with 940 nm diode laser, 
the cellular morphology was clearly confirmed by immunofluorescence and 
in L group. At 1-week post irradiation with 660 nm and 940 nm diode laser,
clear fluorescent signals were observed indicating cellular differentiation. 
The immunofluorescence results for differentiation of ADSCs to chondrocytes 
correspond to the flow cytometry analyses results for both wavelengths and 
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at same time intervals. Consequently, the time interval of incubation after 
irradiation emerges as a vital element for differentiation of ADSCs to 
chondrocytes; subsequently for fibroblasts. The findings of the current study 
have given a motivating confirmation of the differentiation of ADSCs to 
fibroblasts and chondrocytes with two wavelengths. These results could 
support further investigations in the treatment of degenerative TMJ disc. 
Decisively, the combination of photobiomodulation and ADSCs could offer 
solutions for permanent treatment of degenerative changes TMJ disc. All 
previous efforts to apply tissue regeneration of the TMJ disc have mostly 
been misguided with the misinterpretations of the composition and purpose 
of the TMJ disc (Johns and Athanasiou, 2007). However, the 
photobiomodulation on its own is a potential innovative method of 
degenerative TMJ disc management (Kushibiki et al., 2010; Evans et al., 
2007; Mäenpää et al., 2010). A study reported that a wavelength of 808 nm 
promoted an improvement in physical symptoms and jaw disabilities in 
patients (Brochado et al., 2018).  
Therefore, photobiomodulation with 660 nm and 940 nm diode lasers could 
enhance the success of the treatment against TMJ disc disorder. Another 
way of the application of 660 nm and 940 nm diode lasers could be a 
combination with nanomaterials that can advance the development of tissue 
regeneration of TMJ disc (Brochado et al., 2018; Kerativitayanan et al., 
2017). However, improved consideration of the inflammatory mediators in 
TMJ and TMJ disc as a key role participants of cartilage  and collagen 
process of destruction can point to a long lasting option for the management 
of impaired TMJ disc (Barry et al., 2016; Ural et al., 2017; Milam et al., 1995; 
Quinn et al., 1990; Shibata et al., 1998).  
The results of the current study could offer better sustainability of 
photobiomodulation as a clinical treatment for TMD.  Since, the clinical 
studies in dentistry have reported a reduction of pain and inflammation and 
an increase in mouth opening in TMD patients with limitation of mouth 
opening after application of laser at a wavelength of 780 nm, with an energy 
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density of 25 J/cm2 (Salmos-Brito et al., 2013). The wavelength of 808 nm 
among other treatments promoted a reduction in physical symptoms with 
and without pain and enhancement of jaw disabilities in patients (Brochado 
et al., 2018). The laser irradiation with 660 nm and 940 nm diode laser could 
offer even better treatment of TMD patients. 
Further on, in general dentistry, studies confirmed positive outcomes of 
laser treatment. Laser irradiation on its own with 940 nm at 10 J/cm2 fluence 
was reported to stimulate a healing effect on palatal mucoperiosteal wounds 
with possible production of fibroblasts (Firat et al., 2014). Also, 940 nm diode 
laser has significantly reduced pain in patients after undisplaced flap surgery 
and a decrease in postoperative trismus and inflammation (Heidari et al., 
2018; Eroglu and Keskin, Tunc, 2011). Conceivably photobiomodulation 
could enhance stem cell therapy in dentistry. 
Since the stem cell therapies studies in dentistry are on increase. A study 
has reported that human periodontal ligament stem cells (hPDLSCs) 
seeded on calcium phosphate cement (CPC) scaffolds were able to 
differentiate into the osteogenic family of cells giving greater hope for 
enhancement of the bone regeneration in dental, craniofacial and 
orthopaedic applications (Zhao.et al., 2019). In a different study, the 
hPDLSCs were differentiated into osteoblasts, fibroblasts and 
cementoblasts, giving optimistic expectations for better regeneration of 
periodontium (Liu, et al., 2020). 
Hence, the combination of photobiomodulation with 660 nm and 940 nm 
diode laser with/without bFGF on ADSCs could offer more opportunities for 
bettering varieties of treatments in dentistry. This could be explored at the 
various levels of fluences. Also, this could be explored separately with both 
wavelengths. The results of the current study are promising and could 
promote the photobiomodulatory effects of 660 nm and 940 nm diode lasers 
at 5 J/cm2 on ADSCs to induce differentiation into fibroblasts and 
chondrocytes. In the future, these benefits can be explored in periodontology, 
maxillofacial surgery, prosthodontic and TMD fields of dentistry. 
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However, the most important contribution will be the improvement of the 
incapacitating degenerative changes in TMJ disc of patients. This study 
results have opened the door to a new stage of research in tissue 
regeneration of the degenerative changes TMJ disc and possible 























CHAPTER SIX – CONCLUSIONS AND RECOMMENDATIONS 
6.1 Conclusions 
This study concludes the differentiation potential of ADSCs to fibroblasts 
and chondrocytes with laser irradiation at 660 nm and 940 nm at 5 J/cm2. 
The viability and proliferation with different seeding densities at specific time 
intervals were crucial in standardizing the protocol. This study observed 
significant differentiation of ADSCs to fibroblasts and chondrocytes in flow 
cytometry analyses, and immunofluorescence at both wavelengths with and 
without bFGF beyond 72 h. 
As indicated in the results section, change in morphology and drop in 
proliferation of ADSCs beyond 1 week indicated a correlation with their 
differentiation potential to fibroblast and chondrocytes at 1-2 weeks. These
results present strong indication of time dependent differentiation potential 
of ADSCs with laser for future preclinical and clinical studies in tissue
engineering of damaged TMJ disc. This treatment method could provide 
new assistance to patients in distress with TMJ disc malfunction.  
6.2 Recommendations 
The forthcoming research reports should explore sustainability, establish no 
presence of tumorigenic elements in differentiated fibroblasts and 
chondrocytes, and confirm expression of specific genes. Additionally, the 
variation of laser parameters, such as dose, energy, time, and frequency of 
irradiation will be important to determine in future research studies. Also, the 
studies should recognize the interplay of etiologic factors and biochemical 
changes in degenerative TMJ disc. Great attention should be given to an 
appropriate choice of stem cell lineage that is compatible with human tissue.  
The results of this study have established that the use of 660 nm and 940 
nm diode laser at a fluence of 5 J/cm2 and ADSCs could promote the 
application of these lasers in the better treatment of the degenerative TMJ 




6.3 Future directives 
In the next stage, the fibroblasts and chondrocytes obtained from lasers 
differentiated of ADSCs with and without bFGF will be used for the 
replacement of damaged TMJ disc cells in the preclinical and clinical setting. 
At the preclinical level the cells will be transplanted as it was done in the 
study that used the intra-articular injection of ADSCs for knee joint 
deterioration in the rats (Stancker et al., 2018). This technique can be 
followed at the clinical stage for further confirmation of their beneficial role. 
The 660 nm and 940 nm lasers can be recommended to use in combination 
at different time intervals (1-week and 2-weeks) based on the outcomes off 
the current study. 
Furthermore, future studies with the ADSCs and nanolaser as part of the 
nanorobotics application in dentistry could enhance the therapeutic role in 
the clinical treatment of degenerative changes of the TMJ disc cells 
(Bordoloi et al., 2018). The outcomes of the current study will direct future 
studies at preclinical and clinical levels in the replacement of damaged TMJ 
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Guidelines from the Human tissue act, 1983 
Provisions of the Act 
This Act makes provision for the use of tissue, blood and gametes, which 
are removed or excised from a living donor, to be used only for medical and 
dental purposes. This includes the transplantation of tissue, the production 
of a therapeutic, diagnostic or prophylactic substance, blood transfusion, the 
production of blood product and, in the case of gamete, artificial 
insemination (section 19). 
Tissue which may not be used 
Tissue obtained from a mentally disordered patient may not be used for any 
of the abovementioned purposes. Equally, tissue obtained from a minor and 
which is not replaceable by natural processes, or any gamete obtained from 
a minor, may not be used.A minor may therefore donate, e.g. blood or skin. 
A gamete obtained from a habitual criminal may also not be used. 
Placentas, fetal tissue and umbilical cord may not be used except with the 
consent of the Minister of National Health and Population Development, and 
then only subject to the conditions mentioned in the consent (section 19). 
Tissue for transplantation 
The removal of tissue from the body of a living person for transplantation 
purposes may only be affected in an authorized hospital or institution (i.e. 
authorized by the Minister of National Health and population Development). 
The medical superintendent of the hospital or institution must give written 
permission and may not perform the transplant himself (section 20). Note 
that these provisions are not applicable in the case of blood and gametes. 
Removal of tissue 
Removal of tissue, blood and gametes for any of the mentioned purposes 
may only be done with the donor ‘s consent, or in the case of minors with 
the consent of the parents or guardians. The consent must be written. In the 
case of tissue replaceable by natural processes, or blood, the consent 
needs to not be written. Parental consent is also not necessary in the case 
of a minor of 145 years or older who is donating tissue replicable by natural 
processes, and blood. The Act also provides that tissue which is removed 
with the necessary consent from a living donor for the sake of the individuals 
health(e.g. bone removed from a limb amputated after a traffic accident), 



















List of consumables 
 
Product                                
Catalogue no.       
Company/Supplier 
10 mL Disposable pipette           
BD357551  
Beckson Dickinson 
South Africa                   
4 % Paraformaldehyde           
P6148                      
Sigma Aldrich, Merck Group 
South Africa                                
4’6-diamidine-2-phenylindole (DAPI) 
D1306    
Invitrogen™ 
South Africa                                
5 ml Disposable pipette           
BD357543           
Beckson Dickinson 
South Africa                   
Amphotericin B                       
A2942                    
Sigma Aldrich, Merck Group 
South Africa                                
Aqueous Mounting Medium          
F4680                     
Sigma Aldrich, Merck Group 
South Africa                                
Basic fibroblast growth 
factor (bFGF)                              
GF003                    
Sigma Aldrich, Merck Group  
South Africa                                
Biofreezing medium 25 ml            
F2270                     
Biochrom AG 
Switzerland 
BSA                                            
A2153                     
Sigma Aldrich, Merck Group 
South Africa                   
CellTitreGlo 3D ATP kit           
G7573                     
Promega 
South Africa                   
Centrifuge tube, 50 ml, PP flat top, 
sterile, bulk            CR430489 
Corning Incorporated 
USA 
CD26 (clone M-A261, mouse anti 
human) 
MCA1317                  
                                                  
Bio Red Laboratories (Pty) 
Ltd, South Africa   
CD49C (clone P1B5, 
 mouse anti human)                     
MCA5694                
                                                  
Bio Red Laboratories (Pty) 
Ltd, South Africa 
Coverslips                                  
CG88                     
Lasec 
South Africa                   
Dulbecco’s Modified Eagle Medium 
(DMEM)                 D5796 
Sigma Aldrich, Merck Group 
South Africa              
Eppendorf®, Microtubes            
Z666521          
Sigma Aldrich, Merck Group 
South Africa                   
Ethanol absolute 99.99%            
32221                     
Sigma Aldrich, Merck Group 
South Africa            
Field Mate, 0496005 Coherent Power Sens 
detector, USA        
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Falcon (5ml) Polystyrene round 
bottom tube                    BD352054 
Beckson Dickinson  
South Africa                  
Foetal Bovine Serum (FBS)    
10270 106               
Gibco TM 
South Africa            
Hanks Balances Salt Solution (HBSS) 
- 55021C 
Sigma Aldrich, Merck Group 
South Africa                              
Latex Gloves  powder free                       
EV/55620
Thermo Fisher Scientific, 
South Africa
Microscope slides, frosted one end 
size 25 mm x 75 mm  S8400 
Sigma Aldrich, Merck Group 
South Africa            
PBS                                             
A2153                        
Sigma Aldrich, Merck Group 
South Africa            
Penicillin/Streptomycin             
P4333                        
Sigma Aldrich, Merck Group 
South Africa            
Secondary antibody                       
FITC Goat anti-Mouse                            
Biotechnology, Santa Cruz 
USA 
Tissue culture flask 25 cm2, angled 
neck, vent, sterile             
CR/423052 
Corning Incorporated 
USA              
Tissue culture flask 75 cm2, angled 
neck, vent, sterile              
CR/430641U 
Corning Incorporated 
USA     
Tissue culture flask 175 cm2, angled 
neck, vent, sterile              
CR/431080 
Corning Incorporated 
USA                
TrypLE TM Select (500 mL)              
12553-029                  
Gibco 
South Africa                   
Trypan Blue                                    
T8154                
Sigma Aldrich, Merck Group 
South Africa                   
Universal fit pipette tips, 100-1000 µl 
Bulk                          CR4868 
Corning Incorporated 
USA                 
White-walled 96 well plate                     
353, 296                         
BD Biosciences 
South Africa                   











List of Chemicals, Reagents and Media 
 





ATP Substrate Buffer 10 ml 
Complete 
culture media 
45 ml DMEM 
10% FBS  
0.5% Penicillin/Streptomycin 
0.5% Amphotericin  
50 ml 
   5ml 




DAPI Solution  (0.1 mg/ml) DAPI 
9.8 ml Distilled water  
 
10 ml 




















List of Formulas, Measurements and Calculations 
F1. Calculation average laser irradiation times for the diode lasers 
The output power of the 660 nm diode laser was measured using a Field 
Mate Laser Power Meter and the output was mW. 







 Where x = mW 
  π = 3.14 
  Diameter = 3.4 cm 
 
The irradiation time for fluence was then calculated using the power output 






    















List of Equipment 
Name of product Catalogue number Manufacturer/Su
pplier 











940 nm laser 
FC‐655‐300‐MM2‐       
SMA‐1‐0                   
 RGBlase LLC, 
Fremont, CA , 
SMA‐1‐0,  National 
Laser Centre 









Power meter Field Mate 125JO7R National Laser 
Centre 
BD Accuri Flow 
Cytometer C6 






Fluorescent Microscope Axio observer Z1 Carl Zeiss 
Thermo Scientific 
Centrifuge 
Thermo Scientific Thermo Scientific 
Light Microscope Olympus CKX41 Wirsam 
Victor 3 Multiplate 
reader  
1420 Perkin Elmer 
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Abstract
Background: Temporomandibular disorder (TMD) refers to a group of disorders affecting the temporoman-
dibular joint (TMJ) and its related muscles. The two commonly used treatment modalities for TMD are occlusal
splint therapy and relaxation therapy. Neither comprises definitive treatment.
Objective: The objective of this review was to report updated information on photobiomodulation and stem
cells, as an alternative treatment for the degenerative TMJ disc as a part of TMJ disorders.
Materials and methods: With only a few research studies reported till date, this review also proposes the
mechanism of laser irradiation on inflammatory mediators to treat TMD.
Results: Photobiomodulation of stem cells with and without scaffolds could be used indirectly or directly as
modulation of degenerative changes of the TMJ disc.
Conclusions: The need for a distinct shift of the research margin in this field of dentistry is evident, specifically
regarding the application of photobiomodulation and stem cells for tissue engineering of the TMJ disc.
Keywords: tissue engineering, temporomandibular joint disc, photobiomodulation, laser, stem cells
Introduction
Temporomandibular disorders affects the temporo-mandibular joint (TMJ) and its related muscles.1 The
TMJ is described as the most complicated joint in the human
body.2,3 The TMJ is made of mandibular condyle that fits into
a part of the temporal bone named mandibular fossa.4 The
TMJ disc is the structural tissue that keeps these two bones
apart, preventing direct articulation (Fig. 1).
The TMJ and its muscles could undergo acute or chronic
changes with damage to TMJ discs, condyle, and mastica-
tory muscles. Acute temporomandibular disorder (TMD)
could be caused by many factors including injury to the jaw,
TMJ, TMJ disc, and whiplash.5 The sleep bruxism that is
experienced by TMD patients could occur silently during
the night over extended periods, damaging the teeth, TMJ,
and muscles. The process of chronic damage of TMJ struc-
tures can occur without pain.6 It has been recommended that
the Axis-II assessment tools need to be modified to target
diverse populations and cultures. Further on, the lack of
education in undergraduate and postgraduate training in
health care worldwide in the assessment of TMD makes this
disorder a significant social and economic problem.7
Studies have shown that *33% of the general population
show more than one sign or symptom related to TMJ, but
that treatment will only be sought by*5%. The reason why
only such a small percentage of the population seeks help
for this debilitating condition is not well understood. It is
general knowledge that TMD can be part of patient’s life
without symptoms for a prolonged period.8 In most patient
groups female patients predominate, with patients often
experiencing depression linked to TMD.9 TMD can become
a chronic condition in a very short time, with a silent build-
up of symptoms interlinked with occasional systemic dis-
eases. Patients are often not aware that they are developing
this disorder until persistent pain emerges.10 This may be
the reason why TMD patients often seek treatment late in
the development of the disorder. Hence, the damage to TMJ
joint and its structures is advanced by that time presenting a
significant challenge to dentists.11,12
In the search for more definitive solution, photobiomod-
ulation is being introduced as a novel treatment strategy for
TMD. This treatment approach is gaining interest as it de-
creases pain in muscles and improves the chewing function
and mobility of the TMJ.13,14 The application of photo-
biomodulation in general dentistry has been reported to be
effective in reducing pain, swelling, and trismus and stim-
ulates healing of periodontal soft and hard tissues with re-
duction of inflammation.15,16 Furthermore, seven of nine
studies supported the effectiveness of photobiomodulation
1Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Johannesburg, South Africa.
2Department of Prosthodontic and Oral Rehabilitation, and Laser Therapy in Dentistry Division, School of Oral Sciences, Health
Sciences Faculty, WITS University, Johannesburg, South Africa.
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APPENDIX J - PUBLICATIONS
in reduction of pain and quickening of tooth movement in
orthodontic treatment of dentition.17 Research studies have
also indicated that photobiomodulation increases stem cell
migration and stimulates cell proliferation and the regener-
ation of tissue.18
The degenerative changes of TMJ disc are one of the
most complicated parts of TMD to treat. Because the dam-
age is permanent and natural production of TMJ disc cells is
inhibited, the regenerative processes of TMJ discs are in-
terrupted. Therefore, research studies have attempted to
use stem cell therapies to replace the TMJ disc cells, which
are made from two-third fibroblasts and less than one-third
chondrocytes.19 Furthermore, research studies have at-
tempted to renew bone tissue. In recent dental studies, dental
pulp stem cells have been considered as a great source of
cells for bone engineering because they are available in
large quantities and are able to differentiate into bone-like
tissues when seeded on scaffolds in animal models, includ-
ing the culturing of osteogenic cells on several types of
scaffolds. Hence, it has offered hope for bone tissue engi-
neering.20 Moreover, the in vivo study results reported using
nanomaterials in the field of bone regeneration. In a recent
study, the nanocomposite scaffolds of poly glycerol sebacate
(PGS) osteoinductive nanosilicates were used, which were
biocompatible, biodegradable, and did not induce inflam-
mation. The study reported that a combination of bioactive
nanomaterials within a biomaterial scaffold would facili-
tate cell adhesion, proliferation, and differentiation. This is a
promising development in a long-term treatment for those
patients affected by osteoporosis.21 This has given hope for
tissue regeneration of craniofacial defects without the use of
growth factors.22 Furthermore, the human periapical cyst
mesenchymal stem cells (MSCs) have been found to be
very promising in tissue regeneration studies.23 However,
the therapies with the MSCs and other stem cells, scaffolds,
and biomaterials could trigger inflammation and increase
the oxidative stresses additionally to the disease itself caus-
ing an increase in oxidative stress. For example, a research
study reported high levels of oxidative stress in female pa-
tients affected by burning mouth syndrome.24 Hence, using
stem cells, scaffolds, and biomaterials as a regenerative
therapy could increase oxidative stress even more. Perhaps a
combination of photobiomodulation and stem cell therapy
may offer better treatment outcomes.
The conventional treatment of TMD introduces many
challenges. Photobiomodulation and stem cell therapy could
provide opportunities to improve the treatment of damaged
TMJ disc and TMD in general.
The aim of this review was to report the updated infor-
mation on photobiomodulation and stem cells, as an alter-
native treatment method and to explore past and present
questions presented for better future treatment options of the
degenerative TMJ disc as a part of disorders of TMJ.
Etiology of TMD
The TMD is a complex disorder of the TMJ and its
musculature with an even more complex etiology. As is the
case in any other complex disease, the etiology of TMD is
multifactorial. The etiological factors associated with the
TMD could have origin in TMD diseases, but could also be
caused by TMD pain feedback on the human body and/or
from systemic diseases that are linked to TMD.25 Further-
more, a study reviewing research studies assessing the role
of genetic factors leading to TMD reported that the etiology
of TMD could even be linked to many gene polymorphism
associated with higher and lower risks of TMD.26 The eti-
ology of TMD could be found in a neuromuscular source
or/and psychological origin.27 Furthermore, generalized
chronic musculoskeletal pain disorder patients can experi-
ence the same psychological symptoms as TMD patients. In
this case, the etiology of these patient’s diseases could be
arthritic in origin that could affect TMJ.28,29 Another origin
of TMD could be linked to biomechanical and biological
factors such as parafunctions and occlusal overloading.30,31
Another study has mentioned the possibility of increased
estrogen hormones affecting the TMD clinical diagno-
sis.32,33 Stress, anxiety, and depression are frequently linked
to TMD.34 More specifically it has been presented in re-
search studies that acute TMD conditions that are short
time lasting are usually more frequently associated with
anxiety. However, the chronic TMD conditions are more
connected to depression.35,36 Furthermore, TMD may trig-
ger some of psychiatric problems and even medications like
antidepressants could cause TMD.37,38
A study reported that TMD could be connected to fracture
of mandible and whiplash injuries to the head and/or neck as
a result of a road traffic accident.39 Endotracheal intubation
during surgery has also been reported to cause short-term
TMD symptoms in patients because of stress induced to
TMJ structures.40 Hypermobility and systemic hyperlaxity
have also been connected to TMD. Both Marfan and Ehler–
Danlos syndromes are genetic disorders where patients have
experienced TMD caused by hyperextension of TMJ that
could lead to recurrent condylar subluxation or luxation of
the joint.41 The complexity of TMD etiology becomes even
FIG. 1. The figure represents pano-
ramic radiograph of TMJ and full denti-
tion in 20-year-old healthy female
patient. The TMJ is complex joint made
of mandibular condyle that is fitting into
part of the temporal bone named glenoid
fossa. The TMJ disc is situated between
the condyle and glenoid fossa. TMJ, tem-
poromandibular joint.






























































more complicated with emerging research studies exploring
aspects of the biochemical changes related to TMD.
Biochemical Changes Related to TMDs
Only a few research studies in the etiology of TMD and
TMJ degenerative changes have looked at biochemical
changes related to this disorder. However, to improve the
biochemical incidents related to TMDs and TMJ degener-
ative changes, research studies must determine biochemical
profiles of inflammatory contributors to TMDs. Studies
examined and confirmed the central role of reactive oxygen
species (ROS) in the pathogenesis of TMD. This also has
significant implications for both treatment and understand-
ing of the TMD disease.42 A recent study examined aqua-
porins (AQPs), a lineage of hydrophobic membrane channel
proteins, and suggested that AQP1 is found to be present
in the TMJ disc as a part of normal structures, with speci-
ficity to fibrocartilage. The recommendation of this research
finding was that further studies should explore the role of
AQP1 in diseased TMJ discs.43
The genetic disorders Marfan and Ehler–Danlos syndro-
mes are linked to TMD with the biochemical abnormality
concerning fibrous matrix proteins.44 Furthermore, the study
confirmed affirmative associations of visfatin concentra-
tions with TMD pain and internal derangement stage and a
negative correlation with maximum mouth opening. The
osteoarthritis variations in the condyle had considerably
higher concentration of visfatin in contrast to joints with no
presence of osteoarthritis.45 The present studies in synovial
fluid have testified the presence of inflammatory cytokines
and free radicals.46–49 Focus of recent studies is mostly di-
rected to prime promoters of TMD, inflammatory mediators
like arachidonic acid metabolites, neuropeptides, protein-
ases, glycosaminoglycan components, cytokines, and matrix
metalloproteinases.50–54 These inflammatory arbitrators are
playing major roles in deformation of cartilage and colla-
gen that promote movement activities of the mandible. Al-
together, the stress evoked by these mediators may generate
free radicals in the TMJ. The mechanical stress may incite
the production of free radicals in the TMJ by hypoxia–
reperfusion, arachidonic acid metabolites, and proinflam-
matory cytokines. Another research study outlined the
hypothesis of unrestrained free radicals caused by joint over-
burdening.55 These free radicals may lead to destruction of
hyaluronic acid (HA), PG monomer, collagen, and cartilage,
and increase inflammatory cytokines and proteinases in the
TMJ.56
The TMJ articular tissue under normal conditions con-
tains transferrin, ceruloplasmin, albumin, haptoglobin,
ascorbic acid, and tocopheral (vitamin E). However, under
pressure of stressors that are conditioning the joint contin-
uously like direct mechanical injuries, hypoxia–reperfusion
injury, and neurogenic inflammation, this balance is dis-
turbed. It has been shown that the excessive mechanical
loading of articular tissues of TMJ can limit cellular func-
tions, impair fluid transport, and produce free radical mol-
ecules. Hence, the oxygen may be converted to free radical
species by interactions with different molecules situated in
degenerative joints.57
It is evident that the etiological factors interlink and bio-
chemical changes involving inflammatory mediators and
free radicals in TMD patients could diversify both the di-
agnosis and treatment of TMD (Fig. 2). However, cardinal
signs and symptoms can help with narrowing the diagnoses
spectrum.
Cardinal Signs and Symptoms of TMD Patients
The cardinal TMD signs and symptoms, pain in muscles
and/or TMJs, joint sounds, and limitation of movement have
been used to divide patients into two broad diagnostic ca-
tegories. The first group is a myogenous TMD group, with
pain being predominantly originating from muscles that
are part of TMJ complex joint function, whereas in the
second group arthrogenous pain originates from the joint
that is from the TMJ bone structure itself.58 In addition,
patients will report other symptoms linked with TMD, in-
cluding headache, earache, tinnitus, dizziness, numbness
in various areas, allodynia, chronic fatigue, and sleep
FIG. 2. The figure lists several factors
influencing the normal functioning of
TMJ disc. The imbalance in these bio-
chemical and genetic factors lead to
temporomandibular joint disorder. Tar-
geting these factors may be useful in the
treatment of this disorder. TMD, tem-
poromandibular disorder; TMJ, tempo-
romandibular joint.






























































disorders.59 Irritable bowel syndrome and dysmenorrhea
have also been reported as joint functional disorders related
to TMD.60 Furthermore, headaches have been associated
with TMD in a number of studies, and headaches can
complicate the diagnosis of TMD in patients because of
confusing complicated clinical pictures.61,62
Studies have reported that a greater part of patients with
TMD suffered from headaches in comparison with the
general population.63 The headaches could have an origin
in other systemic disorders, diseases, and syndromes. These
could exacerbate and interlink with the original TMD
headaches, and further complicate treatment of TMD.64,65
However, some studies have shown that it is entirely pos-
sible for patients to have headaches and TMD in coexis-
tence with no clinical diagnostic relation. Patients can also
present with facial pain and headaches but with no causa-
tive connection with TMD. Hence, the headaches with no
origin linked to TMD should be treated separately.66 TMD
could also be caused by different states of various dis-
eases, such as Lyme disease and paroxysmal hemicranias.67
The appropriate clinical differential diagnoses can aid better
treatments of TMD patients that present a complex clinical
picture.
The damage to the TMJ disc is slow and chronic. The
complicated combination of the complex etiology and origin
of TMD makes it difficult to diagnose the disorder.
Treatment of TMD
The complexity of the clinical picture of TMD patients
and multifactorial etiology makes the management of TMD
difficult. To improve the treatment results globally, the
Research Diagnosis Criteria for TMD (RDC/TMD) was
developed to establish the standard for evaluation of TMD
named the dual axis system.68 The myofascial pain with or
with no mouth opening restriction was most frequent finding
in TMD patient populaces, and in the community samples
the disc displacement with reduction was the commonest
diagnosis.69 The focal treatment approaches for TMD are
physical therapy, interocclusal splints, pharmacotherapy,
HA joint injection; and botulinum toxin (BTX) type A in-
jection, arthrocentesis, and arthroscopic treatment. A study
has confirmed that the treatment of TMD work best in
combination treatment strategies.70 However, two com-
monly used treatment modalities for TMD patients are oc-
clusal splint therapy and relaxation therapy. A study that
examined 33 patients with TMD and measured the success
of occlusal splint therapy on their symptoms found that 28
of the 33 patients showed a decrease in observable pain
scores.71 In addition, relaxation therapy techniques have
been used to treat TMD. These techniques are based on a
modification of the Jacobson’s technique developed in 1968.
Otherwise named progressive relaxation therapy, it helps
patients to concentrate on specific muscles; with continuous
tensing and relaxing, patients become more aware of their
bodies and physical sensations.72 A research study that used
physical and counseling therapy as treatment for pain in
TMJ muscles in 26 patients reported an improvement of
pain parameters and a function of jaw in patients with pain
in TMJ muscles, in other words myogenous patients.73 How-
ever, none of the above are definitive modalities of treat-
ment for TMD and TMJ disc degenerative changes. Hence,
novel options of treatment including photobiomodulation
may offer significant improvement in treatment.
Photobiomodulation for TMD
In the search for a definitive and alternative modality
of treatment, photobiomodulation has emerged as a pain
therapy for TMD patients.74 Photobiomodulation has been
confirmed to improve immunomodulation, decrease inflam-
mation, and promote wound healing and tissue regen-
eration.75 Researchers now commonly use the term
‘‘photobiomodulation’’ instead of low-level laser therapy.76,77
Lasers are classified according to wavelength and low (vis-
ible) and high output lasers. This classification permits
dentists to decide which lasers to use for different dental
procedures (Table 1). Furthermore, the classification of
dental lasers has been done with consideration of the lasing
medium and material used, including gas laser and solid
laser (Table 2).78
One of the classifications of dental laser is according to
the different affinity of lasers to hard and soft tissues. For
example, the erbium-doped yttrium aluminum garnet laser
(Er:YAG) of 2940 nm wavelength and erbium, chromium-
doped yttrium, scandium, gallium, and garnet (Er:YSGG) of
2780 nm wavelength can be used for hard and soft-tissue
preparation, such as cavity preparation and surgical proce-
dures. On the contrary, diode lasers with 940 nm wavelength
can only be used for soft-tissue procedures. Soft-tissue
lasers cannot be used for the treatment of hard tissues.79 A
study has reported that photobiomodulation could be a
treatment choice in dentistry and it can be applied as an ad-
ditional treatment of oral cavity infection conditions, such as
endodontics and periodontitis, and a treatment modality for
edema, surgical procedures, general oral pain, and muscle
pain.80 The present treatment in TMD with lasers is used for
muscle pain relief and decrease in inflammation.81 Another
research study that looked at the improvement of TMD
symptoms after treatment with 660 nm diode laser and in-
frared 790 nm laser reported improvement in TMD symp-
toms and confirmation of an effective treatment.82
Although photobiomodulation could be a novel, reliable,
safe treatment modality for TMD, current studies have
shortcomings emphasizing the absence of acceptable tech-
nical parameters, exact biological justification, and restric-
ted outcome measures that confines the present value of
these treatments.83 Laser light improves the usual biological
mechanisms in the human body, mainly affecting damaged
cells with decreased oxidation–reduction (redox) reactions.
In this context, the most important effect of laser light on
Table 1. The General Classification of Lasers
to Low (Visible) and High Output Lasers
with Application in Dentistry
Lasers Wavelength Application in dentistry
Ultraviolet 180–400 nm Not used in dentistry
Visible 400–700 nm The most commonly used in
dentistry for diagnoses of
caries (Argon and
Diagnodent Lasers)
Infrared 700–1mm The widest range of dental
lasers are within this range






























































these cells is that it produces an increase of adenosine tri-
phosphate (ATP) in the mitochondria of the cells.84 There-
fore, lasers could offer treatment to TMD patients because
ROS is generated in the TMJ by direct mechanical injury,
hypoxia–reperfusion, and arachidonic acid catabolism to the
articular tissues. It has been observed that amplified groups of
free radicals, biosyntheses of arachidonic acid catabolite,
discharge of neuropeptide and cytokines, and instigation of
matrix damaging enzymes from several TMJ tissues is pro-
duced throughout the stress loading of TMJ. Furthermore,
arachidonic acid catabolism produces prostaglandin E2
(PGE2) and leukotriene B4 (LTB4) in the articular tissues and
excites mast cells and leukocytes to produce a diversity of
propagators of inflammation, cytokines, and free radicals.
ROS affects various molecular types of the TMJ and
deteriorates functioning of the TMJ. For example, the vis-
cosity of synovial fluid in TMJ is reduced by depolymer-
ization and/or molecular configuration of HA and it is one of
the consequences of occurrence of ROS. Another result of
the presence of ROS is decline in the surface-active phos-
pholipid layer that has great role as a lubricant, leading to a
decrease in lubrication of the articular surfaces of TMJ. The
rundown of collagen proteoglycans and triggering of carti-
lage damaging enzymes as it is matrix metalloproteinases
are possible results of ROS. The ROS, especially hydroxyl
radical—HO, powerfully interacts with the membrane lipids
to start a sequence reaction of auto-oxidation that can acti-
vate the manufacturing of carbon-centered, alkoxyl, and
peroxyl radicals. The previously mentioned markers are
participants of lipid peroxidation and of the disruption of
cellular homeostasis.85 The cytokines, interleukin-1 (IL-1),
IL-6, and tumor necrosis factor-a (TNF-a) have been found
in the TMD patients’ synovial fluid. The monocytes–mac-
rophages that infiltrate the synovium of the TMJ produce
cytokines to cause destructive processes in TMJ. Nitric
oxide (NO) is part of this destructive process in TMJ as one
of the free radicals. NO inhibits production of collagen and
proteoglycan synthesis in chondrocytes, modulating me-
talloproteinases and with that increases predisposition to
injury by other oxidants.86
Photobiomodulation and Inflammatory Responses
Inflammatory mediators and inflammation could worsen
TMD. Photobiomodulation has been used clinically for the
treatment of musculoskeletal pains, wound healing, chronic
inflammation, and acute inflammation over the last few
decades.87 It has been reported that photobiomodulation can
encourage an anti-inflammatory outcome by regulating of
transcription factors connected to cyclooxygenase-2 (Cox-2)
and regulating the expression of proinflammatory messenger
RNA (mRNAs). It has been stated that photobiomodula-
tion decreases neutrophil influx and IL-1b mRNA expres-
sion.88,89 Photobiomodulation has been shown to inhibit
production of PGE2 and directed a decrease of Cox-2
mRNA levels.90 Furthermore, several findings have indi-
cated that photobiomodulation inhibits the inflammatory
reaction both in vitro and in vivo. A study that used lipo-
polysaccharide (LPS) to encourage peritonitis in mice es-
tablished that photobiomodulation with gallium arsenide
(GaAs) laser at 904 nm wavelength can decrease inflam-
matory cell movement depending on the dosage.91 Photo-
biomodulation at 780 nm using a diode laser, at an energy
dose of 7.7 J/cm2, reduced the expression of IL-6, COX-2,
and transforming growth factor beta (TGF-b) that has been
linked with collagenase-induced tendinitis,92 whereas using
an aluminum gallium indium phosphide (InGaAlP) laser at
660 nm wavelength considerably decreased the manifesta-
tion of NO, IL-6, monocyte chemoattractant protein 1
(MCP-1), IL-10, and TNF-a.93 An additional study that used
photobiomodulation with human adipose-derived stem cells
(hADSCs) showed that photobiomodulation meaningfully
repressed mRNA expression of proinflammatory cytokines
(Cox-2, IL-1, IL-6, and IL-8) and released proteins (IL-6 and
IL-8), confirming that photobiomodulation has an anti-
inflammatory effect with hADSCs.
Nuclear factor kappa-light-chain-enhancer of activated B
cells (NF-jB) is a vital transcription factor involved in the
regulation of inflammation. Photobiomodulation suppresses
the expression of proinflammatory cytokine genes.94 The
nuclear translocation of NF-jB arises and induces gene
transcription and the phosphorylation state of NF-jB in-
duces NF-jB activation. It has been observed that photo-
biomodulation reduces the level of phosphorylated nuclear
factor of kappa light polypeptide gene enhancer in B cell
inhibitor, alpha (IjBa) and retains more inactive IjBa in the
cytoplasm. Photobiomodulation inhibits LPS-induced ex-
pression of phospho-NF-jB and decreases the amount of
NF-jB that is translocated. The transcriptional activity of
NF-jB was also significantly subdued by photobiomodula-
tion. Photobiomodulation with a 660 nm laser at an energy
density of 7.5 J/cm2 has been found to reduce the mRNA
levels of both B-cell lymphoma-extra-large (Bcl-xL) and A1
mRNA in lung neutrophils obtained from mice subjected to
LPS-induced inflammation, which are produced by NF-jB
nuclear translocation, giving indication that the anti-
inflammatory effect of photobiomodulation can be mediated
by NF-jB,95 whereas photobiomodulation using a 904 nm
laser at an energy density of 5 J/cm2 was able to halt the
decrease of IjBa.96 It inhibits the inflammatory activity
through inhibition of NF-jB transcriptional activity. It has
been reported by a few studies that photobiomodula-
tion upsurges the intracellular levels of cyclic adenosine
monophosphate (cAMP), an important second messenger in
many biological processes, such as cell proliferation, dif-
ferentiation, apoptosis, and inflammation, which is produced
by the activation of adenylyl cyclases and converted from
ATP.97,98 These studies have reported that an increase of
Table 2. The Classification of Dental Lasers









Argon Gas 488–510 nm
Diodes Solid 830–1064 nm
Nd:YAGa Solid 1064 nm
Ho:YAGb Solid 632.8 nm
Erbium Solid 2790–2940 nm
CO2 Gas 9.3–10.6 nm
aNd:YAG: neodymium-yttrium aluminum garnet.
bHo:YAG: holmium-yttrium aluminum garnet.






























































intracellular cAMP levels constrain the transcriptional pro-
cesses of NF-jB and the aptitude of cAMP to manage IjB
kinase (IKK) activity and IjB degradation; and to alter
the structure of NF-jB dimers and in the way inhibit tran-
scription.99–102 Figure 3 simplifies the role of laser and
photobiomodulation on inflammatory mediators to treat
TMD.
The photobiomodulation effect on biological mechanisms
to increase the production of ATP in the human body could
become a useful additional modality for treatment of pain in
TMD patients and other musculoskeletal conditions. Fur-
thermore, the combination of tissue engineering and pho-
tobiomodulation could bring a definitive choice of treatment
to TMD patients.
Tissue Engineering and Photobiomodulation
of Stem Cells as an Alternative Method of Treatment
for the TMJ Disc
The developing science of tissue engineering is providing
an exciting new era for therapeutic dentistry. As a viable
alternative to treat degenerative changes in TMJ disc and
associated muscles of TMD, emerging stem cell therapies
and tissue engineering is starting to take its place as future
modalities of treatment in dentistry and TMD.103,104 Re-
search studies have made an attempt to use the regeneration
of the TMJ disc in a number of variations using cells and/or
biomaterial scaffolds. Used with or without biomolecules,
scaffolds are applied in the construction of tissue-engineered
grafts for transplantation into the tissue, with the purpose
of regenerating damaged TMJ discs. These studies have
attempted to bring novel options of treatment to TMD suf-
ferers.105 However, fewer research studies are recorded us-
ing photobiomodulation and adult stem cells to promote
tissue regeneration in dentistry through photobiomodulation
even that inducing stem cell differentiation may provide a
new and progressive treatment option.106
In medicine, the application of photobiomodulation to
stem cell therapy has been progressing. For example, the
application of photobiomodulation on bone marrow (BM) to
autologous BM to prompt stem cells that are subsequently
engaged to the damaged/ischemic organ, demonstrated that
it is possible to stimulate the patient’s own stem cells to
induce the regeneration of damaged tissue in an organ by
the use of laser light.107 Recently, in dentistry, a systemic
review study reported that data supports the application of
precise settings of photobiomodulation treatment for the
prevention of oral mucositis in cancer patients in particu-
lar patient populations.108 Photobiomodulation offers an
opportunity to use regenerative options itself for the treat-
ment of TMD in clinical dentistry as an alternative to more
conventional, established treatment.109 Photobiomodulation
is less costly and pain liberating where the analgesic ac-
complishment of the irradiation empowers the patient to
return to their responsibilities, providing more consolation
and an improved quality of life.110 Furthermore, scaffolds
seeded with cells and cell injection as a different but in-
terrelated way of tissue engineering could be a future novel
option of TMD treatment.111
Stem cells have self-regeneration abilities and a compe-
tence to differentiate into cell varieties producing mature
cells. The substantial function of tissue homeostasis that
leads to tissue renewal is allocated to MSCs. MSCs are
uncommon pluripotent cells supporting hematopoietic and
mesenchymal cell lines. MSCs are alleged to have thera-
peutic implications for TMD.112 The ideal character of a
stem cell is its ability to self-regenerate and to differentiate
along multiple lineage pathways.113 ADSCs are part of
mesenchymal cell lineages and known to have these qual-
ities and many other advantages allowing ADSCs to be
utilized to restore and renew tissues. One of the many ad-
vantages of ADSCs is that when they are brought into a
damaged or unhealthy tissue, they may discharge cytokines
and growth factors that stimulate recovery in a paracrine




and IL-1b, inhibit production
of PGE2, reduced the expres-
sion of proinflammatory cyto-
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transcriptional activity. Laser
also has impact on inflamma-
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conditions in SF leads to
TMD. However, laser action
may help in the treatment of
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manner.114 ADSCs at the ischemic site make available an-
tioxidants chemicals, free radical scavengers, and chaper-
one/heat shock proteins. This removes harmful constituents
freed into the local environment and encourages revival of
the surviving cells. Additional advantages of ADSCs is that
by a minimally invasive procedure they can be obtained
from abundant adipose tissue, resulting in a high number of
cells.115 It is interesting that to create adipose tissue, the
combination of ADSCs and scaffolds could be used. Some
scaffolds are injectable and an applicable option as mini-
mally invasive therapy.
The advancement in expertise of stem cell research has
presented novel expectations for the treatment and potential
cure of a wide variety of different degenerative disorders
and diseases with no current cure in humans.116 Some of
those treatments are clinical treatment of various bone,
cartilage and musculoskeletal disorders, muscular dystro-
phies, cardiovascular and liver disorders, neuronal diseases,
and diabetes mellitus as well as the bioengineering of fat
and musculoskeletal tissue reconstitution.117,118 A study has
shown that the intra-articular injection of ADSCs and pho-
tobiomodulation stopped joint degeneration in the knee of
the rat with induced osteoarthritis.119 Hence, combination of
ADSCs and photobiomodulation could became a treatment
option for TMJ disc degenerative changes disorder. Other
research studies have indicated that tissue engineering could
provide new clinical treatment modalities for the TMJ disc
with the goal of producing de novo tissue (neo tissues) in the
TMJ disc.120 Furthermore, the tissue engineering approach
offers the method for emerging tissue engineered implants
as clinical treatments for TMJ disc degenerative changes.121
Tissue engineering could offer better options of treatment
specifically of incapacity of fibrocartilage, specifically the
TMJ disc, to undergo regenerative and remodeling processes
after injury. Therefore, the potential regenerative therapy of
injured TMJ disc would be tissue engineering122 and com-
bined with photobiomodulation it could offer more advan-
ced therapy for TMJ disc degenerative changes. A valuable
screening tool for potential tissue engineered solutions
would be in vitro testing.123 In addition, clinical research
needs to be better calibrated in the future.124 This review
also eludes to the possibility of adding chondrogenic and/or
osteogenic cells to biomaterial scaffolds that would increase
the prospects of TMJ tissue regeneration.125 By using pho-
tobiomodulation in dentistry, we can induce regeneration of
the TMJ disc by stimulating the production of the patient’s
own disc cells, which comprise two-third fibroblasts and a
little less than one-third chondrocytes, or by implanting
these cells into the TMJ disc. The application of photobio-
modulation in conjunction with tissue engineering in for-
mation of the novel tissue of the TMJ disc could influence
both the prospect and direction of future studies. There are
strong indications that this research can result in a definitive
treatment for damaged TMJ discs, and ultimately restore the
degenerative TMJ disc to full function.
Concluding Remarks and Outlook
Past and present questions regarding better future treat-
ment options for degenerative TMJ disc and TMD is an
important consideration for dentists. This review recognizes
the interplay of etiologic factors and biochemical changes in
TMD patients that could diversify both the diagnosis and
treatment of TMD. The idea of preventing inflammatory
mediators using photobiomodulation could also design new
research possibilities of TMD treatment. Photobiomodula-
tion and adult stem cells to promote tissue regeneration in
the treatment of TMJ degenerative changes could provide a
new and progressive treatment option. This, together with
the use of scaffolds could indirectly or directly improve
modulation of degenerative changes of TMJ disc, and de-
veloping tissue engineered implants as clinical treatments
for TMJ disc degenerative changes. This review has offered
photobiomodulation and stem cells as a novel option leading
to their use with possibilities of providing a full restoration
of normal functions to patients with TMJ disc damage. The
variation of laser parameters, such as dose, energy, time of
irradiation, and frequency of irradiation will be important to
determine in future research studies. Choosing appropriate
stem cell lineages and their compatibility with human tissue
is also crucial. However, the heterogeneity of parameters
could be overcome by standardization of research and
clinical protocols giving better evidence-based results and
directing research studies to better future research in pho-
tobiomodulation to treat TMD patients.
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TMJ symptoms improve and last across time after treat-
ment with red (660 nm) and infrared (790 nm) low level
laser treatment (LLLT)? A survival analysis. Cranio 2017;
35:372–378.
83. Rahman SU, Mosca RC, Govindool Reddy S, et al.
Learning from clinical phenotypes: low-dose biophotonics
therapies in oral diseases. Oral Dis 2018;24:261–276.
84. Convissor RA. Principles and Practical of Laser Dentistry,
2nd ed. Missouri: Elsevier, 2016, Chapter 15.
85. Kawaia Y, Leeb MC, Kubot E. Oxidative stress and
temporomandibular joint disorders. Jpn Dent Sci Rev
2008;44:145—150.
86. Tomida M, Ishimaru JI, Miyamoto K, et al. Biochemical
aspects of the pathogenesis of temporomandibular joint
disorders. Asian J Oral Maxillofac Surg 2003;15:118–127.
87. Hughes D, Song B. Dental and nondental stem cell based
regeneration of the craniofacial region: a tissue based
approach. Stem Cells Int 2016;2016:8307195.
88. Bortone F, Santos HA, Albertini R, Pesquero JB, Costa
MS, Silva Jr JA. Low level laser therapy modulates kinin
receptors mRNA expression in the subplantar muscle of
rat paw subjected to carrageenan-induced inflammation.
Int Immunopharmacol 2008;8:206–210.
89. Aimbire F, Ligeiro de Oliveira AP, Albertini R, et al. Low
level laser therapy (LLLT) decreases pulmonary micro-
vascular leakage, neutrophil influx and IL-1beta levels in
airway and lung from rat subjected to LPS-induced in-
flammation. Inflammation 2008;31:189–197.
90. Sakurai Y, Yamaguchi M, Abiko Y. Inhibitory effect of
low-level laser irradiation on LPS-stimulated prostaglan-
din E2 production and cyclooxygenase-2 in human gin-
gival fibroblasts. Eur J Oral Sci 2000;108:29–34.
91. Correa F, Lopes Martins RA, Correa JC, Iversen VV,
Joenson J, Bjordal JM. Low-level laser therapy (GaAs
lambda = 904 nm) reduces inflammatory cell migration in
mice with lipopolysaccharide-induced peritonitis. Photo-
med Laser Surg 2007;25:245–249.
92. Pires D, Xavier M, Araujo T, Silva JA, Jr, Aimbire F,
Albertini R. Low-level laser therapy (LLLT; 780 nm) acts
differently on mRNA expression of anti- and pro-
inflammatory mediators in an experimental model of
collagenase-induced tendinitis in rat. Lasers Med Sci
2011:26:85–94.
93. Boschi ES, Leite CE, Saciura VC, et al. Anti- Inflamma-
tory effects of low-level laser therapy (660 nm) in the
early phase in carrageenan-induced pleurisy in rat. Lasers
Surg Med 2008;40:500–508.
94. Akira S, Takeda K. Toll-like receptor signalling. Nat Rev
Immunol 2004;4:499–511.
95. Aimbire F, Santos FV, Albertini R, Castro-Faria-Neto HC,
Mittmann J, Pacheco-Soares C. Low-level laser therapy
decreases levels of lung neutrophils anti-apoptotic factors
by a NF-kappaB dependent mechanism. Int Immuno-
pharmacol 2008;8:603–605.
96. Rizzi CF, Mauriz JL, Freitas Correa DS, et al. Effects of
low-level laser therapy (LLLT) on the nuclear factor
(NF)-kappaB signaling pathway in traumatized muscle.
Lasers Surg Med 2006;38:704–713.
97. Zungu IL, Hawkins Evans D, Abrahamse H. Mitochon-
drial responses of normal and injured human skin fibro-
blasts following low level laser irradiation—an in vitro
study. Photochem Photobiol 2009;85:987–996.
98. Karu TI, Lobko VV, Lukpanova GG, Parkhomenko IM,
Chirkov I. Effect of irradiation with monochromatic vis-
ible light on the cAMP content in mammalian cells. Dokl
Akad Nauk SSSR 1985;281:1242–1244.
99. Gether U. Uncovering molecular mechanisms involved in
activation of G protein-coupled receptors. Endocr Rev
2000;21:90–113.
100. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P,
Ghosh S. The transcriptional activity of NF-kappaB is
regulated by the IkappaB-associated PKAc subunit
through a cyclic AMP-independent mechanism. Cell 1997;
89:413–424.
101. Parry GC, Mackman N. Role of cyclic AMP response
element-binding protein in cyclic AMP inhibition of NF-
kappaB-mediated transcription. J Immunol 1997;159:
5450–5456.
102. Gerlo S, Kooijman R, Beck IM, Kolmus K, Spooren A.
Cyclic AMP: a selective modulator of NF-kappaB action.
Cell Mol Life Sci 2011;68:3823–3841.
103. Arany PR. Photobiomodulation therapy: communicating
with stem cells for regeneration? Photomed Laser Surg
2016;34:497–499.
104. Mehrotra D. Advancing biomaterials of human origin for
tissue engineering. TMJ Bioengineering: a review. J Oral
Bio 2013;3:140–145.
105. Rahman SU, Nagrath M, Ponnusamy S, Arany PR. Na-
noscale and macroscale scaffolds with controlled-release
polymeric systems for dental craniomaxillofacial tissue
engineering. Materials (Basel) 2018;11:1478.
106. Abrahamse H. Inducing stem cell differentiation using
low intesity irradiation: a possible novel therapeutic in-
tervention. Cent Eur J Biol 2011;6:695–698.
107. Oron A, Oron U. Light therapy to stem cells: a new
therapeutic approach in regenerative medicine—a mini
review. JSM Regen Med Bio Eng 2015;3:1016.
108. Zadik Y, Arany PR, Fregnani ER. Systematic review of
photobiomodulation for the management of oral mucositis
in cancer patients and clinical practice guidelines. Support
Care Cancer 2019;27:3969–3983.
109. Carvalho FR, Barros RQ, Gonçalves AS, Freitas PM.
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Laser‐Induced Differentiation of Human Adipose‐Derived
Stem Cells to Temporomandibular Joint Disc Cells
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Background and Objectives: Temporomandibular dis-
order (TMD) is an incapacitating disease with tempor-
omandibular joint (TMJ) disc degenerative changes in pa-
tients. Despite several research attempts to find a definitive
treatment, there is no evidence of a permanent solution. The
objective of the current study was to observe the role of
660 nm diode laser in the differentiation of human adipose‐
derived stem cells (ADSCs) to fibroblasts and chondrocytes.
Study Design/Materials and Methods: After irradi-
ation, the morphology, viability, and adenosine triphos-
phate (ATP) proliferation of the ADSCs were analyzed at
different time intervals. The differentiation of ADSCs
toward fibroblastic and chondrogenic phenotypes was
supported using flow cytometry and immunofluorescence
at 1‐ and 2‐week post‐irradiation.
Results: More than 90% of viable cells were observed
in all experimental groups, with an increase in ATP pro-
liferation. Flow cytometry analyses and immuno-
fluorescence demonstrated the presence of chondrogenic
and fibroblastic cell surface markers at 1‐ and 2‐week
post‐irradiation.
Conclusion: This study has demonstrated methods to
induce the differentiation of ADSCs toward fibroblastic
and chondrogenic phenotypes with a 660 nm diode laser.
The study also proposes a future alternative method of
treatment for patients with degenerative TMJ disc dis-
orders and presents a positive prospect in the application
of photobiomodulation and ADSCs in the treatment of
degenerative TMJ disc. Lasers Surg. Med. © 2020 Wiley
Periodicals LLC
Key words: tissue engineering; temporomandibular joint
disc disorder; photobiomodulation
INTRODUCTION
Tissue engineering and photobiomodulation are
evolving as novel therapies for several diseases in medi-
cine and dentistry [1,2]. The term low‐level laser therapy
has recently been superseded by the term photo-
biomodulation [3,4]. It has been confirmed that photo-
biomodulation turns cells into more alkaline and that
cells are capable of achieving optimal function despite the
low redox state and decreased oxidation [5]. The tempor-
omandibular joint (TMJ) cells with decreased oxidation
will generate reactive oxygen species (ROS) by direct
mechanical injury, hypoxia‐reperfusion, and arachidonic
acid catabolism to the articular tissues. Further on, ROS
affects the viscosity of synovial fluid and deterioration in
the surface‐active phospholipid layer leading to decreased
lubrication of the articular surfaces of TMJ [6]. Photo-
biomodulation can be used as an effective tool to remove
oxidative stresses within damaged TMJ disc cells.
The research studies have used stem cells with bio-
material scaffolds and/or biomolecules to form new cells to
replace damaged TMJ disc cells [7,8]. The capacity to
renew is a characteristic feature of stem cells that clearly
distinguishes them from the other cells [9,10]. An in vitro
study established biodegradable polylactide disks (PLA)
with adipose‐derived stem cells (ADSCs) that could be
encouraging choice for tissue engineering of the fi-
brocartilaginous TMJ disc [11]. The ADSCs are part of
mesenchymal cell lineages that have many advantages.
One of ADSCs' very important advantages is that they
discharge cytokines and growth factors to an unhealthy
tissue, which stimulates recovery in a paracrine manner
[12]. The ADSCs at the ischemic site generate antioxidants
or free radical scavengers and remove damaging elements
encouraging the revival of the surviving cells [13]. More-
over, a research study reported that intra‐articular in-
jection of ADSCs and laser irradiation prevented knee joint
degeneration with induced osteoarthritis [14]. Application
of photobiomodulation on the bone marrow to stimulate
patient's stem cells and to induce regeneration of damaged
tissue is one of the most recent approaches [15,16]. Another
study used a 660 nm diode laser on damaged skeletal
muscle in rats, reported positive effects and an increase in
© 2020 Wiley Periodicals LLC
Accepted 27 September 2020
Published online in Wiley Online Library
(wileyonlinelibrary.com).
DOI 10.1002/lsm.23332
*Correspondence to: Prof. Heidi Abrahamse, PhD, Laser
Research Centre, Faculty of Health Sciences, University of
Johannesburg, P.O. Box 17011, Doornfontein 2028, South Africa.
E‐mail: habrahamse@uj.ac.za
Conflict of Interest Disclosures: All authors have completed
and submitted the ICMJE Form for Disclosure of Potential
Conflicts of Interest and none were reported.
the muscle regeneration process itself [17]. Similarly, a
study that used a 660 nm laser on an injured sternomas-
toid muscle triggered by bupivacaine reported an im-
provement in the muscle regeneration process [18]. This
indicates that photobiomodulation, alone or in combination
with ADSCs, could offer a better treatment for patients
with degenerative changes of the TMJ disc and tempor-
omandibular disorder (TMD).
TMD is the most pervasive recurrent chronic,
nondental‐related persistent pain condition in dentistry
[19]. To confirm the seriousness of this disorder, the
worldwide Research Diagnosis Criteria for TMD (RDC/
TMD) was developed [20–22]. Photobiomodulation has
been introduced as a new method for the treatment
of TMD patients [23]. Additionally, photobiomodulation
increases stem cell migration and stimulate the pro-
liferation and regeneration [24,25]. Studies have con-
firmed positive results for occlusal splint and relaxation
and psychological treatment modalities [26,27]. However,
none of them proved to have a long‐term effect.
The current study observes the role of a 660 nm diode
laser in the differentiation of ADSCs to fibroblasts and
chondrocytes. The study also identifies a future alter-




The immortalized adipose stem cells procured from ATCC
were used (ATCC Cat # SCRC4000™ [Lot # 70003596],
Virginia, USA) for all the experiments. The Academic Ethics
Committee of the Faculty of Health Sciences, University of
Johannesburg, approved this research study (REC‐241112‐
035). A monolayer of ADSCs was cultured in Dulbecco's
modified Eagle's medium (D5796; Sigma Life Science,
Johannesburg, South Africa) supplemented with 10% fetal
bovine serum (Gibco™ 10270 106, Johannesburg, South
Africa), 1% penicillin/streptomycin (P4333; Sigma Life Sci-
ence), and 1% Amphotericin B (A2942; Sigma Life Science).
The stem cell cultures were incubated at 37°C with 85%
humidity and 5% carbon dioxide (CO2).
Laser Differentiation of ADSCs to Fibroblasts and
Chondrocytes
The ADSCs were characterized and their identity was
confirmed before seeding. The cells were cultured in a
175 cm2 flask and harvested at 80% confluence with
TrypLE™ Select (12553‐029; Gibco®). The cell viability
percentage was determined with an automated cell
counter (Countess® II FL; Invitrogen, LTC Tech South
Africa Pty LTD, Fairland, Johannesburg, South Africa)
using trypan blue assay and the viable cell number was
used to optimize cell seeding density (Table 1). The ex-
perimental groups include cells grown at 24, 48, and
72 hours and at 1, 2, and 3 weeks. In order to achieve
optimum cell confluence (not more than 90%), different
seeding densities were optimized. Our attempt to monitor
the cells with similar seeding densities led to over
confluence, multilayer growth, and increased cell death
with increased incubation time. To avoid such errors and
to observe suitable results beyond 72 hours required dif-
ferent seeding densities. Cell growth was monitored in a
3.4 cm diameter culture dish (430588; Corning, The Sci-
entific Group, Johannesburg, South Africa) with 2ml of
complete media. The images were captured using an in-
verted light microscope (Wirsam Scientific, Olympus
CKX41, Johannesburg, South Africa).
The experiment was divided into four groups. Group C
was a control group of ADSCs with no laser irradiation
and basic fibroblast growth factor (bFGF) (Sigma‐Aldrich,
Merck Group, South Africa, GF003, Johannesburg, South
Africa), Group LB with bFGF added at 10 ng/ml, before
irradiation, Group B with bFGF (10 ng/ml) and no irra-
diation and ADSCs exposed to laser irradiation alone,
Group L. The bFGF used in this study is a known strong
mitogen for many cell types and it is found as a part of
basement membranes, and subendothelial extracellular
matrix of blood vessels in the normal tissue [28–30]. The
irradiated and non‐irradiated ADSCs were re‐incubated
at 37°C in a humidified atmosphere of 5% CO2.
The irradiation of ADSCs was done with 660 nm diode
laser at a fluence of 5 J/cm2 with a continuous wave (FC‐
655‐300‐MM2‐SMA‐1‐0; RGBlase LLC, Fremont, CA),
provided and set up by the National Laser Centre (NLC) of
the Council for Scientific and Industrial Research (CSIR),
South Africa. The power output was read by using the
Field Mate Laser Power Meter (Field Mate, Power Sens
detector, 0496005; Coherent, Western Cape, South Africa).
The read values of power output were used to calculate the
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All the laser parameters were recorded (Table 2).
TABLE 1. Seeding Density Optimization of Adipose‐
Derived Stem Cells
Time period Number of cells
24 hours post‐irradiation group 5 × 105
48 hours post‐irradiation group 3 × 105
72 hours post‐irradiation group 3 × 105
1‐week post‐irradiation group 1 × 104
2 weeks post‐irradiation group 5 × 103
3 weeks post‐irradiation group 5 × 103
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Morphology and Trypan Blue Exclusion Assay
Microscopic evaluation of cells was performed with an
inverted light microscope at 24, 48, 72 hours and 1‐,
2‐, and 3‐week post‐irradiation. The trypan blue viability
assay was performed (T8154; Sigma‐Aldrich, Johannes-
burg, South Africa) to determine cellular viability. The
trypan blue only enters impaired, leaky membranes of
dead cells, resulting in unstained and colorless viable
cells. An equal volume of cells and trypan blue (10 μl) were
mixed by pipetting. The cell viability percentages were
obtained from the automated cell counter.
Adenosine Triphosphate (ATP) Proliferation
The ADSCs were trypsinized and resuspended in com-
plete media to perform ATP proliferation experiments. The
Luminescent cell viability assay (CellTiter‐Glo® 3D;
Promega, Anatech Instruments, Johannesburg, South
Africa) was performed to establish the number of viable
cells in the stem cell culture. The change of ATP to ad-
enosine monophosphate (AMP) by the enzyme luciferase
produces luminescence, which is measured with this assay.
This assay enables the quantification of intracellular ATP
and the assessment of mitochondrial activity, which is an
indication of the existence of energy‐storing active cells as
a direct indicator of cell proliferation [31,32]. Equivalent
volumes of cell suspension and reagents (50 μl) were added
in a white‐walled 96‐well plate (353, 296; BD Biosciences,
Woodmead, Johannesburg, South Africa) and mixed on a
shaker for 5minutes to provoke cell lysis; and incubated for
25minutes at room temperature in the dark to stabilize the
luminescent signal. Triplicate of each experimental group
(C, LB, B, and L) was maintained during the study. The
emission of the light signal was read in relative light units
(RLU) with Victor 3 multiplate reader (Perkin‐Elmer,
Midrand, Johannesburg, South Africa).
Flow Cytometry Analysis
After repeated attempts, little to no differentiation was
observed in groups, other than at 1 and 2 weeks. Hence, the
percentage of ADSCs' differentiation toward fibroblastic
and chondrogenic lineages at 1‐ and 2‐week post‐irradiation
was determined with the expression of CD26 (clone
M‐A261, mouse anti‐human; Bio Rad Laboratories (Pty)
Ltd., Johannesburg, South Africa) used at 1:100 μl
phosphate‐buffered saline (PBS) dilution in all experimental
groups and CD49C (clone P1B5, mouse anti‐human; Bio Rad
Laboratories (Pty) Ltd.) at 1: 200 μl of PBS dilution in L
group. The ADSCs were cultured to 80% confluence and
trypsinized. The ADSC suspension was centrifuged at 400g
for 5minutes at room temperature. The supernatant was
discarded, and the cell pellet was resuspended in 1ml of
room temperature PBS (A2153 and S8032; Sigma,
Johannesburg, South Africa). A cell count and viability were
performed using the automated cell counter. After cell count,
1× 106 of the cells were added into a focus tube in 100 μl cold
(4°C) PBS. Ten microliters of the primary antibody were
added into 100 μl of cells in PBS and vortexed. The cells were
then incubated in the dark for 30minutes and washed three
times using PBS and centrifuged at 400g for 5minutes at
room temperature. In the next stage, 10 μl of the secondary
antibody (FITC Goat anti‐Mouse; Santa Cruz Biotechnology,
Anatech Instruments, Johannesburg, South Africa) was
added into 100 μl cell suspension and vortexed. Thereafter,
the cells were incubated in dark for 30minutes and rinsed
three times with PBS and centrifuged at 400g for 5minutes
at room temperature. The cells were then resuspended in
300 μl of PBS for the immediate flow cytometry reading. The
detection of fluorescence (dye‐stained cells) was performed
using the Accuri C6 flow cytometer (BD Biosciences) and
compared with the gated control unlabeled group of ADSCs.
The fluorescence was detected using FL‐1 with a 533/30
filter and a 488nm laser.
Immunofluorescence
The surface markers of the cells, intracellular proteins,
and other cellular antigens can be detected under a fluo-
rescent microscope. The direct, indirect, and complement
binding immunofluorescence methods are the best‐
recognized ones [33,34]. In this study, the indirect im-
munofluorescence protocol was used to confirm the
differentiation of ADSCs to fibroblasts in all experimental
groups (L, LB, and B) and to chondrocytes in L group at 1‐
and 2‐week post‐irradiation. The cells were cultured on a
heat sterilized coverslip in a 3.4 cm diameter culture plate
with 2ml of complete media at a concentration of 1 × 104
for 1‐week and 5 × 103 cells/plate for 2‐week post‐
irradiation. The ADSCs were then irradiated at a fluence
of 5 J/cm2 with 660 nm diode laser and cultured for 1 and
2 weeks. Thereafter, the cells in separate experimental
groups were washed three times with cold PBS (A2153;
Sigma) and fixed in 4% paraformaldehyde (P6148; Sigma)
for 15minutes in the dark. Cells were then incubated with
blocking buffer (10% [w/v]) bovine serum albumin for
30minutes at room temperature as a blocking step and
washed three times again using cold PBS. After blocking,
the cells were incubated with 100 μl primary antibody
CD26 (mouse anti‐human; 1:100 μl of PBS dilution) for
1 hour in the dark and rinsed three times with PBS. The
slides were then labeled and incubated with 100 μl of the
TABLE 2. Laser Parameters Used for Irradiation of
Adipose‐Derived Stem Cells With 660 nm Diode Laser
Laser type Semiconductor diode
Wavelength 660 nm
Wave emission Continuous
Spot size 9.1 cm2
Output power (mW) 24, 48, and 72 hours—97,1
1, 2, and 3 weeks—98,25
Power density (mW/cm2) 24, 48, and 72 hours—10,6
1, 2, and 3 weeks—10,8
Fluencies 5 J/cm2
Irradiation times calculated
with reading of power
output
24, 48, and 72 hours—
7.48minutes
1, 2, and 3 weeks—
7.42minutes
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secondary fluorescent FITC Goat anti‐mouse antibody
(1:100 μl of PBS dilution) for 1 hour in the dark. In an-
other set of experiments, the steps were repeated with
100 μl of CD49C (1:200 μl of PBS dilution). After the final
rinse with PBS, the cells were counterstained with
4′,6‐diamidino‐2‐phenylindole (DAPI) (D1306, 358Ex/
461Em; Invitrogen™) and mounted on glass slides using
Fluoromount™ the aqueous mounting medium (F4680;
Sigma). The slides were viewed under a fluorescent mi-
croscope live‐cell station from Carl Zeiss Axio Z1 Observer
using AxioVision imaging software (Carl Zeiss, Randburg,
Johannesburg, South Africa) at ×200 magnification.
Statistical Analyses
The Sigma Plot version 13.0 was used for statistical
analysis. The statistical analysis of Student's one tail
t test was applied. The one‐tail t test data was plotted
on the graphs with * symbol indicating the statistical
significance: *P< 0.05, **P< 0.01, ***P< 0.001.
RESULTS
Cell Morphology and Viability
At 24, 72 hours and 1‐week post‐irradiation,
proliferation was evident in morphological images
(Fig. 1). The morphology and confluence at 2 and 3
weeks were similar to that observed at 1 week. In
control, a decline in proliferation was observed at 1, 2,
and 3 weeks. However, proliferation was evident be-
yond 72 hours in all other groups with laser irradiation
and bFGF.
More than 90% of viability was recorded in all ex-
perimental groups. A statistical significance of P< 0.05
Fig. 1. Cellular morphology of ADSCs at 24 and 72 hours and 1‐week post‐irradiation with
660 nm diode laser. All cells appear viable and healthy with definitive spindle‐shaped morphology.
At 72 hours, ADSCs in all the groups showed an increased proliferation of cells. At 1‐week, a
decline in the proliferation of ADSCs in the control group (0 J/cm2 and no bFGF) can be seen,
compared with other experimental groups. The effect of laser and bFGF in cell proliferation can
be clearly seen even beyond 72 hours of treatment. ADSC, adipose‐derived stem cells; bFGF, basic
fibroblast growth factor.
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was recorded in group L at 72 hours compared with the
control group (Fig. 2).
ATP proliferation
Since different seeding densities were used for the ex-
perimental groups, ATP proliferation of treatment sets
was compared with their respective controls within the
same time interval. A significant increase (P< 0.01) in
ATP was recorded in groups L and B at 1 week, and in
group LB at 72 hours post‐irradiation. While at 48 hours,
group L had the highest ATP proliferation (Fig. 3).
Flow Cytometry
The differentiation and expression of markers in the ex-
perimental groups up to 72hours and at week 3 appeared
minor. Hence, the results represented are of weeks 1 and 2.
The expression of CD26 marker for fibroblasts was confirmed
in LB, B, and L groups at 1‐ and 2‐week post‐irradiation.
Fig. 2. Trypan blue viability of ADSCs assessed at different time intervals post‐irradiation with
660 nm diode laser. The statistical analysis was done with student's one‐tail t test compared with
their respective controls within the same time interval. All groups of cells indicated high viability.
At 72 hours, depending on the cell seeding density, the laser‐treated group was statistically
significant. ADSC, adipose‐derived stem cells.
Fig. 3. The ATP cellular proliferation was assessed at 24, 48, and 72 hours and 1‐week post‐
irradiation with 660 nm diode laser. The statistical analysis of ATP proliferation in experimental
groups was performed with student's one‐tail t test compared with their related controls within
the same time interval. The cellular proliferation of ADSCs as assessed by ATP. The ATP
proliferation was evident in all irradiated groups of cells with and without bFGF compared with
control cells. The result depicts the significant role of bFGF and laser in cell proliferation and an
increase in ATP. As represented, at 72 hours, cells in the treatment group showed a significant
increase in ATP compared with cells in other groups. ADSC, adipose‐derived stem cells; ATP,
adenosine triphosphate; bFGF, basic fibroblast growth factor.
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Unlike for fibroblasts, ADSC differentiation to chondrocytes
was observed in group L alone. The experimental groups
were compared with a control group of ADSCs that had no
markers. The highest percentage (28.27%) of CD26 ex-
pression was recorded at 1‐ and 2‐week (25.37%) post‐
irradiation in group LB (Table 3). The expression of CD49C
marker for chondrocytes was higher in group L, at 1‐week
(19.13%) than 2‐week (1.23%) post‐irradiation (Table 3). The
Figures 4A and B and 5A and B represent the differentiation
percentage of the best variable group and the table with
average differentiation percentages of all experimental
groups.
Immunofluorescence
A similar differentiation pattern was observed in
groups for immunofluorescence study. The immuno-
fluorescence results further supported the differentiation
of ADSCs toward a fibroblastic phenotype based on the
expression of CD26 marker in all the experimental groups
(LB, B, L) at 1‐ and 2‐week post‐irradiation. Figures 6A
and B represent the best‐captured expression pattern of
CD26 marker among the experimental groups and in
group L. Further on, the expression of CD49C marker
also supported the differentiation of ADSCs toward a
TABLE 3. Flow Cytometry Experimental Groups with Percentages of Differentiation
Flow cytometry experimental groups
B LB L
CD26 at 1‐week post‐irradiation 23.46%± 9.1%** 28.27%± 3.6%** 21.63%± 0.7%**
CD26 at 2‐week post‐irradiation 10.80%± 0.2%** 25.37%± 3.0%*** 18.40%± 2.8%***
CD49C at 1‐week post‐irradiation 19.13%± 2.96%
CD49C at 2‐week post‐irradiation 1.23%± 0.0%
The experimental groups of cells are labeled as follows: C, control; LB, laser and bFGF; B, bFGF; and L, laser. The statistical
significance is presented as **P < 0.01, and ***P < 0.001; SEM compared with control cells with no irradiation and basic fibroblast
growth factor added within the same time interval.
Fig. 4. Flow cytometry showing the positive expression of CD26. (A) Expression of CD26 at
1‐week post‐irradiation showing percentages of differentiation in different groups. The highest
percentage of expression is observed in group B at 1‐week and (B) at 2‐week post‐irradiation,
group LB had the highest expression of CD26 compared with the unstained–control group
(without irradiation and bFGF). bFGF, basic fibroblast growth factor.
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chondrogenic phenotype at 1‐ and 2‐week post‐irradiation
in group L (Figure 7A and B).
DISCUSSION
The purpose of this study was to observe the effect of
660 nm diode laser at a fluence of 5 J/cm2 in the differ-
entiation of ADSCs into fibroblasts and chondrocytes.
Even though photobiomodulation and stem cell therapy
research have recently emerged in greater numbers, only
a few studies have reported interesting findings beyond
72 hours of post‐irradiation [35–39]. The uniqueness of
the current study is that the results have established the
photobiomodulatory effects on ADSCs beyond 72 hours
and at 1, 2, and 3 weeks. Additionally, at a fluence of
5 J/cm2, the results of the current study confirmed an
increase in ATP proliferation at 24 and 48 hours; and
beyond 72 hours. This concurs with results of a similar
study reported at 24 and 48 hours, diabetic‐wounded
fibroblasts showed a significant increase in proliferation
when irradiated with 830 nm diode laser at a fluence of
5 J/cm2 [40]. An increase in the mitochondrial oxidative
mechanism caused by the excitation of components of the
respiratory chain leads to an increase of ATP, which is an
effect that photobiomodulation expresses on the cells
[41,42]. Consequently, the current study results empha-
size the importance of ATP luminescence and evidence on
the therapeutic applications of 5 J/cm2 against degener-
ative TMJ disc disorder.
The results also were detailed, with all experimental
groups having a high percentage of cellular viability post‐
irradiation, confirmed by the trypan blue exclusion assay. A
related result was reported in the studies that had an in-
crease in cellular viability, proliferation, and differentiation
after using photobiomodulation (980 and 660 nm) [43,44].
Furthermore, the flow cytometry and immunofluorescence
results of the current study support differentiation of ADSCs
toward fibroblastic and chondrogenic phenotypes at 1 and
2 weeks. Similarly, a laser‐induced differentiation was tes-
tified in ADSCs, where a fluence of 5 J/cm2 at 636nm in-
duced differentiation into smooth muscle cells [45]. Another
study using 810nm laser documented significant differ-
entiation of bone marrow‐derived mesenchymal stem cells
(BMSCs) into neurons [46].
The effect of 660 nm at 5 J/cm2 was observed in a study
that reported in diabetic‐wounded cells differentiation of
fibroblasts into myofibroblasts [47]. Likewise, the flow
cytometry analyses to determine the differentiated
Fig. 5. Flow cytometry showing the positive expression of CD49C. In the groups representing the
expression of CD49C marker, the higher percentage of expression is seen at 1‐week post‐
irradiation, (A) than at 2‐week post‐irradiation, (B) compared with the unstained–control group.
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fibroblast‐like cells showed statistically significant re-
sults in B group at 1‐ (mean value at 23.46%) and 2‐week
(mean value at 10.80%) post‐irradiation. Additionally,
the high percentage of differentiation was recorded in LB
group at the same time intervals compared with non‐
irradiated‐unlabeled cells. These results have given en-
couraging the possibility of combined application of laser
and bFGF for the differentiation of ADSCs to functional
fibroblasts.
In the differentiation of ADSCs to chondrocytes, the use
of bFGF experimental groups was excluded to exclude the
interference of fibroblast and to report on the effect of
laser beam alone. Recently, a study used lasers alone (810,
660, 532, and 485 nm) on mesenchymal stem cells derived
from rabbit iliac bone marrow for differentiation to bone
or cartilage [48]. In the present study, the expression of
the CD49C marker was confirmed using flow cytometry in
group L only at 1‐ and 2‐week post‐irradiation compared
with their respective control group. This was sub-
sequently confirmed with immunofluorescence. A similar
result of photobiomodulation was observed in the study
that used 405 nm, blue laser to differentiate the pre-
chondrogenic ATDC5 (Mouse 129 teratocarcinoma AT805
derived) cells into chondrocytes [49]. These results
indicate that the duration of incubation after irradiation
could be a crucial factor for the differentiation of ADSCs
to fibroblasts and chondrocytes.
Hence, photobiomodulation on its own can be recom-
mended as a possible novel approach for the treatment of
degenerative TMJ disc disorder. Also, the combined appli-
cation of laser irradiation with 660 nm at 5 J/cm2, and
nanomaterials without growth factors could improve the
process of tissue regeneration [50,51]. Since the TMJ disc is
made of two‐thirds of fibroblasts and less than one‐third
of chondrocytes, the results of the current study are
promising and could promote various future investigations
in TMJ disc tissue regeneration. A study described a novel
treatment modality with the regeneration of spinal cord
disks after the transplantation of fibroblasts into degen-
erated spinal disks of the rabbit [52]. It could be postulated
that one could use differentiated ADSCs to replace the
apoptotic cells of TMJ disc by process of transplantation.
However, the previous research attempts to use tissue re-
generation for the TMJ disc have been mostly misconceived
due to misunderstandings of the constitution and function
of the TMJ disc [53]. Moreover, a better understanding of
inflammatory mediators in TMJ and TMJ disks, which
play a major role in the process of deformation of cartilage
Fig. 6. Immunofluorescent microscopic images confirm the differentiation of ADSCs to
fibroblasts. In the figure, green fluorescence (FITC) represents the expression of CD26
confirming the differentiation of ADSCs to fibroblasts in group L at 1‐ (A) and 2‐week (B) post‐
irradiation. The nuclear counterstaining DAPI is represented in blue color. The fibroblast
morphology can also be clearly seen in the figure. DAPI, 4′,6‐diamidino‐2‐phenylindole; FITC,
fluorescein isothiocyanate.
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and collagen, could lead to a permanent solution for the
treatment of degenerative TMJ disc [54–58].
In the future, additional studies will examine the laser‐
induced differentiation of ADSCs to fibroblasts and
chondrocytes using advanced techniques. These may in-
clude gene expression studies and western blot analysis to
confirm the specific expression patterns of marker genes
and proteins, such as collagen type I alpha 1 (COL1A1)
and type II (COL2), SRY‐Box transcription factor 9
(SOX9), and aggrecan (ACAN) genes, as well as collagen I
and collagen II proteins.
CONCLUSION
In conclusion, this study has observed significant re-
sults in viability, ATP proliferation, flow cytometry anal-
yses, and immunofluorescence after 72 hours of 660 nm
diode laser irradiation and has provided evidence to
support the differentiation of ADSCs to fibroblastic and
chondrogenic phenotypes. This treatment approach can
provide a novel aid to patients suffering from TMJ disc
abnormalities. However, future research studies should
examine sustainability, expression of specific genes to
determine cell differentiation, confirm no presence of tu-
morigenic factors of differentiated fibroblasts and
chondrocytes, and inspect a wider range of laser wave-
lengths with a profound observation of biochemical proc-
esses. The outcome of this study has demonstrated that
the application of 660 nm diode laser at a fluence of 5 J/
cm2 and ADSCs could be a positive drive in the direction
of better treatment of the degenerative TMJ disc.
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